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1. Introduction 
 
1.1 History of cardiovascular diseases 
 
1.1.1 History of stroke 
 
Stroke was first described by Hippocrates (460 to 370 BC) in antiquity who called it 
“apoplexy”, which - in Greek - means "struck down by violence". This was due to 
the fact that stroke patients developed sudden paralysis, change in well-being and 
convulsions followed by injuries to the brain. It was known that paralysis was on 
the opposite side to the wound. Hippocrates also described aphasia for the first 
time when writing about paralysis of the right arm with loss of speech (Pound et al, 
1997; Thompson, 1996). 
In 1599 the word “stroke” was used for the first time as a synonym for apoplexy 
and is a fairly literal translation of the Greek term (Pound et al, 1997). 
In the 17th century Johann Jakob Wepfer wrote a monograph on apoplexy. He 
found out from his autopsy studies that patients who died with apoplexy had 
bleeding in the brain. He also identified the main arteries supplying the brain, the 
vertebral and carotid arteries and discovered that apoplexy might be caused by a 
blockage in one of the brain's blood vessels so that the nutrients supply was 
disrupted (Thompson, 1996). 
Study of the cause, symptoms, and treatment of apoplexy was continued. Finally, 
at the beginning of the 20th century apoplexy was divided into categories, those 
caused by obstruction and those caused by haemorrhage and the terms "cerebral 
disease" emerged (Pound et al, 1997). 
 
1.1.2 History of myocardial infarction 
 
Since the beginning of the 19th century it has been known that coronary 
thrombosis might be fatal.  
In 1901, the German scientist Krehl for the first time reported that coronary 
thrombosis not always caused death and that there may be complications like 
ventricular aneurysm and myocardial rupture.  
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Several years later Obrastov, Strazhesko, and Herrick described the clinical 
characteristics of acute myocardial infarction. They also established the difference 
to angina pectoris. 
After the find that a myocardial infarction is not necessarily fatal, research on 
treatment was developed. In 1912 James Herrick established the importance of 
rest in postinfarction recovery with bed rest up to 6 weeks. Furthermore James 
Herrick introduced electrocardiography for diagnosis of acute myocardial infarction 
which is still in use. 
In the 1950s Bernard Lown found out that the time of recovery for patients of 
cardiovascular diseases was cut down by decreasing the time of rest due to 
reduced risk of deep venous thrombosis and pulmonary embolism (Sarmento-
Leite, 2001). 
 
1.2 Global prevalence of cardiovascular diseases  
According to the World Health Organisation cardiovascular diseases are the 
principal cause of death worldwide. In 2005 about 17.5 million people died from 
cardiovascular disease which is 30% of all global deaths. 7.6 million people died 
due to heart attacks and 5.7 million due to stroke. Not only in industrialized 
countries cardiovascular disease is the most common cause of death, about 80% 
of the globally counted death caused by cardiovascular disease occurred in low- 
and middle-income countries (WHO, 2007). 
Cardiovascular diseases account for about 49% of death in Europe (55% of death 
in women and 43% of death in men) and 42% in the EU (46% of death in women 
and 39% of death in men) and is the main cause of death in all countries of 
Europe except among men in France and San Marino (Petersen et al, 2005). 
Cardiovascular diseases account for 36.3% of total mortality in the USA. In 2004 
the estimated prevalence of cardiovascular diseases was 37.1% in both sexes, 
37.5% in men and 36.6% in women with a mortality rate of 11.0% for both sexes 
(Rosamond et al, 2007). 
If current trends may be continued, by 2015 estimated 20 million people will of 
from cardiovascular diseases, mainly of heart attacks and strokes (WHO, 2007). 
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1.3 Cardiovascular diseases – biological background 
 
Atherosclerosis 
 
The basic mechanism of cardiovascular diseases is atherosclerosis. The 
endothelium regulates the vascular homeostasis which means the balance 
between vasodilatation and vasoconstriction and exerts anticoagulant, antiplatelet 
and fibrinolytic properties (Davignoon & Ganz et al, 2004). Endothelial dysfunction, 
an early marker of atherosclerosis, can be induced by elevated low-density 
lipoproteins (LDL), free radicals, infectious microorganisms, shear stress, 
hypertension or toxins after smoking and is associated with decreased nitric oxide 
synthesis. An inflammatory response plays a major role in the progression of 
atherosclerosis (Stoll and Benszus, 2006). Oxidized lipoprotein, T-cells and 
macrophages enter into the vessel wall which leads to enhanced oxidative stress 
in vascular cells and to an activation of intracellular signalling molecules. T-cells 
recognize oxidized LDL, heat shock proteins and shared microbial antigens and 
locally release pro-inflammatory cytokines. Cell adhesion molecules are up-
regulated which facilitates the adherence of leukocytes to the dysfunctional 
endothelium and their transmigration into the vessel wall. The inflammatory 
response leads to initiation of atherosclerotic plaques formation and to their 
destabilization. The rupture of plaque causes most acute coronary syndromes like 
myocardial infarction, unstable angina, and coronary death (Fuster et al, 2005; 
Stoll, 2006). 
 
Atrial fibrillation 
 
Atrial fibrillation represents an early stage of cardiovascular diseases and indicates 
increased risk for cardiovascular diseases. During atrial fibrillation the contraction 
of the atrias is totally uncoordinated resulting from the abnormal electrical impulse. 
As a result blood is not pumped out completely and can clot. If a blood clot leaves 
the heart and reaches an artery of the brain, stroke can occur. People with atrial 
fibrillation have a five time increased risk of stroke (Savelieva et al, 2008; Thews et 
al, 1999; S199) 
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Cardiovascular diseases 
 
Cardiovascular diseases (CVDs) are a group of disorders of the heart and blood 
vessels including coronary heart disease, cerebrovascular disease, peripheral 
arterial disease, rheumatic heart disease, hypertension, congenital heart disease 
and heart failure (WHO, 2007). 
 
“Acute coronary syndrome” is the term used for describing patients who present 
with either acute myocardial infarction or unstable angina (Rosamond et al, 2007). 
Coronary heart diseases are caused by blocking or narrowing of the coronary 
arteries because of atherosclerotic changes in the blood vessels. Hereby oxygen 
and nutrient supply of the heart muscle are disrupted. This can cause angina 
pectoris or a heart attack. In angina pectoris the balance of oxygen supply to 
oxygen use of the heart muscle is destroyed which causes chest pain that can 
also spread over shoulders and arms. Stable angina is exercise induced with no 
symptoms occurring at rest. Unstable angina varies in frequency and severity and 
can occur during intensive exercise and at rest. In a myocardial infarction or 
heart attack the blood flow through a coronary artery is totally blocked and 
because of this a myocardial ischemia necrosis of an area of the heart muscle 
occurs. A number of complications can accompany a cardiac infarction like cardiac 
arrhytmia, mechanic failure of the heart muscle, insufficiency of the mitral valves, 
aneurysmas and rupture of the heart septum and disruption of the papillar muscle. 
The location of the infarct scars over. If the scar is spread over a small area only, 
the heart is able to fully recover. If the scar spreads over a larger area, heart 
insufficiency can develop (Thews et al, 1999, S209-11). 
 
The cerebrovascular disease stroke is caused by a disruption of the blood 
supply to the brain. An ischemic stroke occurs, if arteries are blocked by blood 
clots or by the gradual build-up of plaque and other fatty deposits. A hemorrhagic 
stroke results from a rupture of a blood vessel in the brain mainly because of 
hypertension (Thews et al, 1999). The consequences of a cerebrovascular event 
depend on the location and dilatation of the infarction. Approximately 20-30% of 
the patients die within the first week, often because of secondary complications 
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like cerebral oedema, pneumonia, heart insufficiency or infections. Approximately 
one third of the patients remain in need of care (Thews et al, 1999; S691).  
 
Rheumatic heart disease occurs as a complication of rheumatic fever which is 
caused mainly by an infection with streptococcal bacteria. It is observed in the 
development of damage to the heart muscle and weak valvular conditions 
(Girschik et al, 2008).  
 
A congenital heart disease is caused by a malformation of heart structures 
existing at birth. The most common heart defects are patent ductus arteriosus, the 
artery which normally closes after birth, atrial and ventricular septal defects which 
can cause the blood to circulate improperly, valves abnormalities and stenosis of 
the aorta valve, pulmonal stenosis or coarctation of the aorta (Thews et al, 1999; 
S207). 
 
Other cardiovascular diseases are aortic aneurysm or dissection, peripheral 
arterial disease or pulmonary embolism. Aortic aneurysm is defined as a local, 
permanent dilatation and aortic dissection is defined as a rupture of the aorta 
(Thews et al, 1999; S261). A peripheral arterial disease is atherosclerosis of the 
arteries supplying the arms or legs like the iliac, femoral, popliteal and tibial 
arteries. In deep venous thrombosis blood clots occur in the leg veins which can 
move to the heart or lungs causing pulmonary embolism. This effect is capable 
of causing permanent damage of the affected lung, low oxygen levels in the 
patient´s blood or damage to other organs caused by lack of oxygen. If the clot is 
too large, the embolism can be fatal (Thews et al, 1999; S261). 
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1.4 Cardiovascular risk factors 
 
1.4.1 Metabolic syndrome 
 
An excess of body fat, especially visceral fat is a key factor for developing 
metabolic syndrome, which is defined as the coexistence of hyperglycaemia, 
hypertension, hyper- and dyslipidemia and central obesity. The International 
Diabetes Federation (IDF) has defined the metabolic syndrome as follows (Alberti 
et al, 2006): 
• central obesity defined as waist circumference with ethnicity specific values: 
≥94 cm for male Europids and, ≥90 cm for male South Asians, Chinese and 
Japanese and ≥80 cm for female Europids, South Asians, Chinese and 
Japanese. 
plus any two of the following four factors:  
• raised triglycerides ≥150 mg/dL (1.7 mmol/L) or specific treatment for this 
lipid abnormality. 
• reduced HDL (high density lipoprotein) cholesterol of <40 mg/dL (1.03 
mmol/L) in males and <50 mg/dL (1.29 mmol/L) in females or specific 
treatment for this lipid abnormality. 
•  raised blood pressure: systolic blood pressure ≥130 or diastolic blood 
pressure ≥85 mm Hg or treatment of previously diagnosed hypertension.  
• raised fasting plasma glucose (FPG) ≥100 mg/dL (5.6 mmol/L), or 
previously diagnosed type 2 diabetes.  
 
The WHO has established the following diagnostic criteria for the metabolic 
syndrome (Khatib, 2006):  
• abdominal obesity: in men waist circumference >102 cm (>40 inches), in 
women waist circumference >88 cm (>35 inches). 
• high levels of triglycerides: at least 150 mg/dL,  
• low HDL cholesterol: in men <40 mg/dL, in women <50 mg/dL, 
• high blood pressure: at least 130/>85 mmHg 
• high fasting glucose: at least 110 mg/dL 
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According to WHO at least three of the five criteria shown must be met to 
diagnose metabolic syndrome. Several other components of the metabolic 
syndrome have been described (e.g. hyperuricaemia, coagulation disorders) but 
are not considered criteria for its diagnosis (Khatib, 2006) 
Cardiovascular diseases are more prevalent among patients with this syndrome 
(Lakka et al, 2002; Ridker et al, 2003; Howard et al, 2003; McNeill et al, 2005). 
The risk for coronary heart disease and stroke was increased threefold in subjects 
with the syndrome. Cardiovascular mortality was significantly increased in subjects 
with the metabolic syndrome from 2.2 to 12.0 % (Isomaa et al, 2001). It has to be 
considered that the cardiovascular risk factors have a multiplicative and not an 
additive effect on the incidence of coronary heart disease (Grundy et al, 2006).  
 
1.4.2 Risk factor obesity 
 
Overweight defined as a BMI (body mass index) between 25 and 29.9 and obesity 
defined as a BMI over 30 kg/m2 predispose for higher cardiovascular disease risk.  
In the Health Professionals Follow-Up Study, males with a BMI >30 had a 4 times 
higher risk of cardiovascular mortality than those with a BMI <23.62. In further 
studies it was shown that cardiovascular risk increases with higher waist 
circumference. In women a higher risk was reported with waist circumferences >38 
inches compared with waist circumferences <30 inches. In further studies it was 
shown that men with a waist circumference of <38 inches had less cardiovascular 
risk than men with a circumference of >38 inches (Retelny et, 2008). 
Obesity is independently correlated to the risks of developing coronary heart 
disease, atrial fibrillation, and heart failure. This can be partly explained by the 
higher prevalence of other cardiovascular risk factors in overweight or obese 
people like hyper- and dyslipidemia, diabetes type 2 and hypertension. Especially 
visceral obesity contributes to or causes most other modifiable risk factors, like 
hypertension and type 2 diabetes mellitus (Zalesin et al, 2008; Retenly et al, 
2008). Even modest weight loss (7% to 10% of body weight) results in a 
decreased fat mass, blood pressure, glucose, low-density lipoprotein, and 
triglyceride levels (Pritchett et al, 2005).  
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Obesity can enhance cardiovascular disease through various mechanisms like 
systemic inflammation, hypercoagulability, and activation of the sympathetic and 
renin-angiotensin systems (Zalesin et al, 2008). This is caused by the adipose 
tissues which is an active endocrine organ producing a great variety of hormones 
and cytokines which are involved in glucose metabolism, lipid metabolism, 
inflammation, coagulation and blood pressure. Obesity causes an elevated 
secretion of adipokines which enhance development of diabetes mellitus, 
metabolic syndrome and atherosclerosis (Hajer et al, 2008).  
 
1.4.3 Risk factor hyper-/ and dyslipidemia 
 
Hyperlipidemia is defined as an increased level of one or more cholesterol 
fractions and dyslipidemia is defined as an adverse lipoprotein ratio such as an 
increase of LDL level and triglyceride level and a low HDL level (Thews et al, 
1999).  
Obesity, especially abdominal obesity, promotes the progression of dyslipidemia 
like high plasma concentrations of triacylglycerol in the fasted state, low high 
density lipoprotein cholesterol (HDL) concentrations and higher concentrations of 
small dense low density lipoproteins (LDL). A low level of body fat is associated 
with high levels of HDL cholesterol (Hardman et al, 1999).   
The ATP III (Adult Treatment Panel III) classifies the LDL-cholesterol levels as 
follows (NCEP, 2002) according to the proposed risk for developing coronary heart 
disease: 
 
• <100 mg/dl as optimal,  
• 100-129 mg/ml as above optimal, 
• 130-159 mg/ml as borderline high, 
• 160-189 mg/ml as high, 
• >190 as very high. 
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The ATP III (Adult Treatment Panel III) classifies the total-cholesterol levels as 
follows (NCEP, 2002): 
• <200 mg/dl desirable,  
• 200-239 mg/ml as borderline high, 
• >240 as high. 
 
LDL is the major atherogenic lipoprotein, whereas HDL protects against the 
development of atherosclerosis. One percent decrease in HDL cholesterol is 
associated with a 2–3 percent increase of a coronary heart disease risk (Gordon et 
al, 1989). The main mechanism by which cholesterol increases cardiovascular 
disease risk is its action as a key component in the development of 
atherosclerosis. Mainly by accumulation of fatty deposits on the inner lining of 
arteries, cholesterol increases the risks of ischaemic heart disease, ischaemic 
stroke and other vascular diseases (WHO, 2002). 
In several studies the association between serum cholesterol level and 
cardiovascular diseases was determined. The summary of ten cohort studies 
shows that there is an association between ischaemic heart disease and the 
serum cholesterol level which decreases with age. For men a decrease of serum 
cholesterol concentration of 0.6 mmol/l or about 10% led to a reduction of the risk 
of ischaemic heart disease of 54% at age 40 years, 39% at age 50 years, 27% at 
60 years, 20% at 70 years, and 19% at 80 years. The average reduction of 
mortality of ischaemic heart disease in three international studies for men aged 55-
64 years was 38%. For women the decrease in serum cholesterol concentration 
led to a similar reduction in the risk of ischaemic heart disease as in men (Law et 
al, 1994).  
 
1.4.4 Risk factor diabetes 
 
On the contrary to type I diabetes which is characterized by an absolute lack of 
insulin due to the destruction of the insulin producing beta cells of the pancreas, 
type II diabetes is characterized by a combination of insulin resistance and an 
inadequate compensatory insulin secretory response. Insulin resistance is defined 
as inadequate target organ responsiveness or sensitivity to insulin. As a result, 
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higher concentrations of insulin are needed to compensate this disturbance which 
causes a hyperinsulinemia. As a consequence of the high insulin levels, insulin 
receptors of peripheral tissue are down-regulated. The resulting lack of glucose in 
the cells is associated with increased blood glucose level. This causes a further 
enhancement of insulin production of the beta cells. If this condition persists for 
longer, beta cells become insufficient and are finally unable to produce a sufficient 
amount of insulin (Thews et al ,1999, p. 515; Expert Committee on the Diagnosis 
and Classification of Diabetes Mellitus, 2003). 
The metabolic stage between normal glucose homeostasis and diabetes is defined 
as “impaired fasting glucose” or prediabetes and as a fasting blood glucose level 
of 110 - 126 mg/dl glucose. Diabetic patients have a fasting blood glucose level of 
126 mg/dL or greater (Expert Committee on the Diagnosis and Classification of 
Diabetes Mellitus, 2003).  
Diabetes represents a major independent risk factor for cardiovascular disease. In 
the Framingham study a twofold to threefold increased risk of clinical 
atherosclerotic disease was shown based on a time period of 20 years (Kannel et 
al, 1979; NCEP, 2002). Furthermore the 1-year, 28 day and out-of hospital 
mortality rate after coronary heart disease in diabetic subjects has been found out 
to be much higher than in non-diabetic men and women (Miettinen et al, 1998). 
Besides coronary heart disease and cerebrovascular disease, retinopathy, 
nephropathy, peripheral neuropathy, peripheral vascular disease and diabetic food 
are the major complications of diabetes. In developed countries diabetes is one of 
the leading causes of blindness, renal failure and lower limb amputations 
(International diabetes federation, 2003). 
 
1.4.5 Risk factor hypertension 
 
Hypertension is defined as a blood pressure ≥140 mmHg systolic or ≥90 mmHg 
diastolic or current use of antihypertensive medication (Chobanian et al, 2003). 
Several studies have shown an association of high blood pressure with the risk for 
cardiovascular diseases (Van den Hoogen et al, 2000; Staessen et al, 1997). Even 
in subjects with high-normal blood pressure (130–139 mmHg systolic and/or 85–
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89 mmHg diastolic) the risk for developing cardiovascular diseases is increased 
(Vasan et al, 2001). 
In men over 50 an elevated systolic blood pressure (SBP) is a more relevant 
cardiovascular disease risk factor than the diastolic blood pressure (DBP). Starting 
at 115/75 mmHg, the risk for developing a cardiovascular disease doubles for 
each increase of 20/10 mmHg. The mortality for an ischemic heart disease and 
stroke increases linearly from 115 mmHg SBP and 75 mmHg DBP upwards. With 
an increase of SBP for 20 mmHg or DBP for 10 mmHg mortality doubles. The 
Framingham Heart Study showed that over a longer period of time blood pressure 
values between 130–139/85–89 mmHg are associated with a more than twofold 
increase in relative risk for developing a cardiovascular disease as compared with 
those with BP levels below 120/80 mmHg (Chobanian et al, 2003). 
There are several mechanisms which link hypertension with cardiovascular 
disease prevalence. Elevated blood pressure favours bleeding of the brain and 
hereby the development of stroke. Furthermore hypertension enhances the 
formation of atherosclerotic changes of the vessel walls which can lead to 
coronary heart diseases or renal insufficiency. In hypertonic stage the heart has to 
work harder permanently which can cause heart insufficiency (Thews, 1999; 
S250). 
 
1.4.6 Lifestyle factors 
 
Smoking 
Epidemiologic studies have proved that exposure to cigarette smoke is an 
important risk factor of cardiovascular morbidity and mortality. Several 
mechanisms are responsibly, including vasomotor dysfunction, changing of the 
lipid profile, oxidation of low-density lipoprotein cholesterol, modification of 
prothrombotic effects, including altered platelet function, and deregulation of 
antithrombotic, prothrombotic, and fibrinolytic mechanisms and inflammation (Cole 
et al, 2008). Smoking affects all stages of atherosclerosis from endothelial 
dysfunction to acute clinical events. Free radical-mediated increase of oxidative 
stress through cigarette smoking seems to play a central role in the development 
of athero-thrombotic diseases and the initiation of cardiovascular dysfunction. 
Enhanced by various prothrombotic and antifibrinolytic effects, intravascular 
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thrombosis is the predominant cause of acute cardiovascular events (Ambrose et 
al, 2004).  
Smoking cessation leads to partial reversion of smoking-induced airway 
inflammation and endothelial dysfunction in healthy ex-smokers, but not in those 
with chronic obstructive pulmonary diseases. Furthermore smoking cessation is 
associated with an improvement of cardiovascular function and a reduction of the 
risk of primary cardiovascular morbidity and mortality (Gratziou et al, 2009). 
 
Lack of exercise 
Lack of exercise is associated with increased risk for developing cardiovascular 
diseases and diabetes. Conversely, physical activity improves several 
cardiovascular risk factors such as lowering LDL and triglyceride, increasing HDL 
levels, improving glucose metabolism and lowering blood pressure (WHO, 2002; 
Ignarro et al, 2007). Physical training leads to several adaptations in the human 
body as to a more efficient system for oxygen transfer to the muscle so that 
unlimited lipid stores can be used instead of the limited carbohydrate reserves 
(Poirier et al, 2001). Furthermore regular physical activity contributes to weight 
reduction and hereby decreases the development of dyslipidaemia. One 
mechanism is the increase of the metabolic capacity for triacylglycerol, maybe 
through an increased activity of the lipoprotein lipase (Hardman et al, 1999). 
Diabetic adults who performed slight exercise (walking > 1 mile per day) were able 
to significantly reduce their all cause mortality and the mortality caused by 
cardiovascular diseases to less than one-fifth (Smith et al, 2007). 
The global prevalence of physical inactivity among adults is estimated to 17% and 
the estimated prevalence of insufficient activity (which means <2.5 hours per week 
of moderate activity) ranged from 31% to 51%, with an average of 41%. The WHO 
estimated physical inactivity to be attributable for about 10–16% of diabetes 
mellitus, and about 22% of ischaemic heart disease globally (WHO, 2002). 
 
Unhealthy diet 
A healthy diet including fruit and vegetables helps to prevent cardiovascular 
diseases as proved by several studies (He et al, 2006). A recently performed 
meta-analysis showed that the risk of coronary heart disease is decreased by 4% 
for each additional portion of fruit and vegetables per day and by 7% for fruit 
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consumption (Dauchet et al, 2006). Consuming fruits and vegetables is related to 
a lower prevalence of important cardiovascular risk factors including hypertension, 
obesity, and type 2 diabetes mellitus. This may be caused by several ingredients 
as antioxidants or other micronutrients like flavonoids, carotinoids, vitamin C, folic 
acid or dietary fibers. Furthermore a diet rich in fruits and vegetables has a low 
dietary glycemic load and energy density (Bazzano et al, 2003). Low fruit and 
vegetable intake is estimated to be attributable to 31% of ischaemic heart disease 
and 11% of strokes worldwide. Globally 2.7 million (4.9%) estimated deaths are 
caused by low fruit and vegetable intake, of which about 85% were from 
cardiovascular diseases and 15% were from types of cancer (WHO, 2002). 
Furthermore the intake of dietary fibers is negatively associated to cardiovascular 
disease risk, partly explained by their LDL-cholesterol lowering effect (Retenly et 
al, 2008). The profile of fat intake also has a considerable effect on the risk of 
developing cardiovascular diseases. High intakes of dietary saturated fatty acids, 
trans-fatty acids, and cholesterol increase serum total cholesterol and LDL-
cholesterol levels in a dose-dependent manner. From these types of fatty acids, 
trans-fatty acids have the most negative effect on elevating the ratio of serum total 
cholesterol to HDL-cholesterol. Unsaturated, ω-3 fatty acids like eicosapentanoic 
acid decreased cardiovascular mortality in animal studies. These fatty acids act by 
reducing serum triglyceride levels, reducing inflammatory response and favourably 
affecting platelet function. In the Chicago Western Electric Study the negative 
association of ω-3 fatty acids consumption and relative risk of death from coronary 
heart disease was shown (Retenly et al, 2008). 
 
Low socioeconomic status (SES) 
There is an inverse relationship of low SES and the risk of developing a 
cardiovascular disease. In national longitudinal studies in several European 
countries like Finland, Sweden, Norway, Denmark, England/Wales and Italy lower 
SES indicated by educational level and occupational class is associated with a 
higher overall mortality of diseases among men and women. This socioeconomic 
gap is seen in mortality rates of cardiovascular diseases but also of lung cancer, 
breast cancer, respiratory diseases and gastrointestinal diseases (Mackenbach et 
al, 2003). 
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In another study the relationship of the socioeconomic status with C-reactive 
protein level (CRP), a non-specific marker of inflammation which is associated to 
cardiovascular risk was systematically reviewed. It was found out that the CRP 
levels among adults were inversely associated with the socioeconomic position 
(Nazawi et al, 2007) 
The higher prevalence of cardiovascular disease is associated with a higher 
prevalence of the risk factors like high blood pressure and diabetes. Furthermore 
the socioeconomic status might affect the prevalence for cardiovascular diseases 
through lifestyle factors like higher smoking rates and chronic emotional stress 
(Kim et al, 2008). Furthermore the utilization of invasive procedures for 
cardiovascular treatment such as cardiac catheterization, coronary artery bypass 
graft or percutaneous transluminal coronary angioplasty and use of medications is 
lower for persons in lower socioeconomic position (Callier et al, 2004; Barnato et 
al, 2005). 
 
Psychosocial stress 
Chronic stress can be defined as a state of disrupted homeostasis which is 
counteracted by physiologic and behavioural responses which aim to reestablish 
the challenged body equilibrium, called “adaptive stress response”. The 
hypothalamic-pituitary-adrenal axis and the autonomic nervous system represent 
the two main components which regulate the vital functions of the stress system. It 
is proposed that chronic stress is associated with disruption of the metabolic 
homeostasis. This could contribute to the development of visceral obesity, type 2 
diabetes, atherosclerosis and metabolic syndrome. The mechanism of this 
correlation is based on the chronic hyperactivation of the hypothalamic-pituitary-
adrenal axis under prolonged stress, which favours the accumulation of visceral 
fat. In addition to this, fat tissue itself causes a chronic inflammatory state by 
secretion of adipokines by the adipocytes and pro-inflammatory cytokines that 
contribute to further derangement of the metabolic equilibrium (Kyrou & Tsigos, 
2007; Kyrou & Tsigos, 2008). 
Several studies investigated the relationship of stress and cardiovascular 
diseases. In a recent study a high level of trait anger was associated with 
developing hypertension from prehypertension and incidence of coronary heart 
disease after adjusting for various covariates. This fact was more predictive for 
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men. Long-term psychological stress was associated with an increased risk of 
developing an incident coronary heart disease in men and women (Player et al, 
2007). Surtees et al showed a significant association of increased psychological 
distress like emotional distress with an elevated stroke risk, whereas in this study 
a major depressive disorder did not influence the incident stroke (Surtees et al, 
2008).  
A recent review shows that acute stress, chronic stress and particularly the non-
adaptive response to stress promote the elevation of blood pressure as the major 
cardiovascular risk factor. Chronic stress was – as shown in the study - mostly 
caused by occupational stress indicated by working hours, forms of work 
organization, the anxiety of keeping the job, the self estimation to be “average or 
not good at doing the job”. The non-adaptive response to stress was indicated by 
hopelessness, severe stress and “tension-anxiety” (Sparrenberger et al, 2009). 
Interestingly, in a recent study it was found that the association between 
psychological distress and cardiovascular disease risk can be largely explained by 
behavioural patterns. In situations of psychological distress people more often 
tend to smoke, drink alcohol or they become physically inactive (Hamer et al, 
2008). 
 
Alcohol consumption 
There is an inverse relationship between cardiovascular disease and moderate 
alcohol consumption which means one drink per day for women and two drinks 
per day for men. The protective effect of moderate alcohol consumption has been 
explained by increasing serum HDL cholesterol levels and decreasing aggregation 
on platelets by lowering levels of fibrinogen and protein tissue-type plasminogen 
activator. This leads to a reduced rate of coronary artery obstruction (Retenly et al, 
2008; Ignarro et al, 2007). Furthermore it was shown that moderate drinking may 
improve the early outcomes after acute myocardial infarction and prevent sudden 
cardiac death. A direct effect of ethanol on the ischemic myocardium has been 
suggested (Ignarro et al, 2007). 
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1.4.7 Non-modifiable risk factors 
 
Age 
The cardiovascular risk increases with increasing age and becomes clinically 
significant in men in their mid-forties and in women during and after menopause. 
The main reason of the increase of the risk with age is the progressive 
accumulation of atherosclerosis which is caused by the cumulative exposure to 
atherogenic risk factors (NCEP, 2002). 
 
Sex 
Women are significantly older than men when suffering from the first myocardial 
infarction, an effect that effectively contributes to the difference in life expectancy 
between men and women. The risk of developing a cardiovascular disease in 
women is about 10 to 15 years delayed in comparison to men (Wilson et al, 1998). 
The lifetime risk for developing cardiovascular diseases is 50% at age 40 years for 
men and 30% for women (Lloyd-Jones et al, 1999). This difference can be partly 
explained by the earlier occurrence of cardiovascular risk factors in men such as 
dyslipidemia and an elevation of blood pressure (Wilson et al, 1998). It has been 
observed that cardiovascular risk factors influence the outbreak of cardiovascular 
disease depending on the gender. Diabetes, HDL blood levels and triglycerides 
have been found to have a greater impact on the coronary disease risk in women 
than in men (Roeters van Lennep et al, 2002).  
Before menopause cardiovascular disease rarely occurs among women (Lloyd-
Jones et al, 1999). This effect can be explained by the protective effect of the 
female hormones - especially estrogen - which affects the lipid profile and the 
vascular function (Roeters van Lennep et al, 2002).  
 
Family history 
A family history of premature cardiovascular disease is an independent risk factor 
for developing cardiovascular diseases like a coronary disease (Fischer et al, 
2007), myocardial infarction or venous thromboembolism (Braekkan et al, 2008). A 
familial predisposition is assumed when a myocardial infarction is diagnosed 
concerning a male first degree relative before his 55th year of life or a female first 
degree relative before her 65th year of life. The relative risk for cardiovascular 
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disease in first-degree relatives ranges from two to 12 times to that of the general 
population and increases with the number of primary relatives affected. For female 
patients it was shown to be more common than for male patients to have first-
degree relatives with coronary artery disease before the age of 65 (Pohjola-
Sintonen, 1998; Rissanen et al, 1979). The familial aggregation of cardiovascular 
disease can be partly explained by the fact that several cardiovascular risk factors 
are also under genetic control such as blood pressure, lipids and lipoproteins and 
obesity (Williams et al, 2001). 
In a recent study it was found that offsprings of patients suffering from myocardial 
infarction had decreased postheparin LPL activity associated with an increased 
postprandial triglyceride-rich lipoproteins and an adverse lipid profile like 
decreased HDL cholesterol. Those factors may contribute to their increased risk 
for future coronary events (Lekhal et al, 2008). 
 
Ethnicity  
The rate of cardiovascular diseases differs with ethnicity. In a recently performed 
systematic review non-white ethnicity was associated with elevated C-reactive 
protein (CRP) levels among adults. Blacks, Hispanics and South Asians had 
significantly higher levels than Whites (Nazmi et al, 2007). In another recent study 
the prevalence of stroke among American Indians and African Americans was high 
with estimated 5.1% and 3.2%, among whites it was 2.5%, and among Asians it 
was 2.4% (Rosamond et al, 2007).  
The prevalence of cardiovascular risk factors varies between individuals of 
different races. Especially in Hispanic and black people the prevalence of 
cardiovascular risk factors like diabetes, hypertension and dyslipidemia is high 
(Clark et al, 2007; Colleran et al, 2007). 
 
1.5 Prevalence of cardiovascular risk factors 
 
1.5.1 Prevalence of obesity  
 
Obesity is a severe world-wide health problem, which has been increasing rapidly 
over the last decade and has almost reached epidemic proportions by now. 
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According to the World Health Organization, in 2005 approximately 1.6 billion 
adults (age ≥ 15 years) were overweight and at least 400 million adults were 
obese. For 2015 an increase up to approximately 2.3 billion overweight adults and 
more than 700 million obese persons worldwide has been estimated. This 
tendency can not only be observed in high income countries, but also in low- and 
middle income countries (WHO, 2006). 
 
1.5.2 Prevalence of diabetes 
 
The increase in the prevalence of diabetes type 2 is closely related to obesity 
augmentation. The number of people with diabetes worldwide was estimated as 
246 million in 2007 which is a prevalence of diabetes of 5.9% of the adult 
population (20-79 age group) and has been expected to increase to 380 million 
people with diabetes in 2025 which is a prevalence of 7.1% of the adult population 
(International Diabetes Federation, 2006)a. Analogue to the obesity prevalence, 
diabetes has been increasing not only in developed countries, but also in low- and 
middle income countries. The highest prevalence of diabetes occurs in several 
countries of the Middle East (United Arab Emirates shows a rate of 19.5 %, Saudi 
Arabia 16.7 %, Bahrain 15.2%, Kuwait 14.4%, Oman 13.1%, Egypt 11.0%), in 
certain Pacific countries (up to 30.7%), Mauritius (11.1%) and Mexico (10.6%). 
Eastern Mediterranean countries have a rate of 9.2% and the North American 
Region shows 8.4%. The highest absolute number of diabetic people live in India 
(40.9 million), China (39.8 million), USA (19.2 million), Russia (9.6 million) and 
Germany (7.4 million) (International Diabetes Federation, 2006).  
 
1.5.3 Prevalence of hypertension 
 
According to an international survey prevalence of hypertension lies between 
27.4% in Canada and 55.3 % in Germany with an average of 44.2 % for the six 
                                            
a
 The mentioned prevalence of diabetes is referred to total diabetes rate because the sources of most 
countries do not distinguish between type 1 and type 2 diabetes (Wild et al 2004). According to IDF type 2 
diabetes accounts to 90-95 % of total diabetes (International Diabetes Federation, 2006).  
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European countries Italy, Spain, Sweden, England, Finland and Germany (Wolf-
Maier et al, 2003). The global prevalence for hypertension was estimated for 1 
billion individuals. Furthermore approximately 7.1 million deaths per year are 
caused by hypertension which is about 13% of total deaths. Suboptimal BP (>115 
mmHg SBP) is attributable to 62 percent of cerebrovascular diseases and 49 
percent of ischemic heart disease (WHO, 2002). 
 
1.5.4 Prevalence of hyper- and dyslipidemia 
 
In the Multi-Ethnic Study of Atherosclerosis which was performed in USA with 
Black, White, Hispanic and Chinese men and women between 45 and 84 years 
29.3 % of the total population had dyslipidemia. The highest prevalence was found 
among white men with 36.9 % and the lowest among Chinese women with 21.0 % 
(Goff et al, 2009). In Germany the average prevalence of hyperlipidemia was 
estimated to 37.0% in 1998 (Laaser et al, 2005). According to WHO Global 
InfoBase the estimated prevalence of hyperlipidemia (total cholesterol > 240 
mg/dl) in certain European countries like Italy, Austria, Netherlands, Finland and 
United Kingdom ranged from 8.0 to 44.4% in women and 14.0 to 27.1% in men 
aged between 45-80 years. The increase of the prevalence with age in all 
mentioned countries is much higher in women than in men (WHO, 2009). 
It is estimated that high cholesterol causes 18% of cerebrovascular diseases and 
56% of ischemic heart diseases worldwide. Overall this leads to about 4.4 million 
deaths which are 7.9% of total deaths. In most regions, the proportion of female 
deaths attributable to cholesterol is slightly higher than that for men (WHO, 2002). 
 
1.6 Measuring the progress of cardiovascular diseases 
 
Several indicators are suitable for measuring the progress of cardiovascular 
diseases in a subclinical stage like the level of C-reactive protein, the progress of 
atherosclerosis and myocardial ischemia. 
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C-reactive protein (CRP)-level 
CRP is a sensitive marker for vascular inflammation. Several studies showed a 
relation between baseline concentration of CRP and future CVD events. In the so-
called “Physicians’ Health Study” it was found that healthy men with CRP-levels in 
the highest quartile had a twofold elevated risk of stroke, a 3-fold elevated risk of 
myocardial infarction, and a fourfold elevated risk of developing severe peripheral 
arterial diseases (Greenland et al, 2000). 
 
Subclinical atherosclerotic disease 
Subclinical coronary atherosclerosis is associated with the risk for major coronary 
events (Smith et al, 2000) and can be measured by the following methods: ankle-
brachial blood pressure index, carotid intima media thickness (IMT) and coronary 
calcium. 
 
Ankle-brachial blood pressure index (ABI) 
The ABI serves as a measure for lower extremity peripheral arterial disease 
(PAD). Systolic blood pressure in the brachial, the posterior tibial, and the dorsalis 
pedis arteries is measured. An ABI of <0.9 is characteristic of PAD which is often 
associated with other cardiovascular risk factors. Consequently the ABI can be 
used as a diagnostic test for identification of persons at high risk for coronary heart 
diseases (Criqui et al, 1992). 
 
Carotid intima media thickness 
The extent of carotid atherosclerosis correlates positively with the extent of 
coronary atherosclerosis. Carotid intima media thickness of the carotid arteries 
can be measured by carotid sonography (Greenland et al, 2000). Several studies 
proved that the severity of IMT correlates with risk for coronary events (Chambless 
et al, 1997). 
 
Coronary calcium 
The amount of coronary calcium correlates with coronary plaque burden which 
indicates subclinical coronary atherosclerosis. Coronary calcium can be measured 
by electron beam computed tomography (Smith et al, 2000).  
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Myocardial ischemia 
Myocardial ischemia can be tested by exercise electrocardiogram (ECG) testing, 
myocardial perfusion imaging, and stress echocardiography. A positive exercise 
ECG in asymptomatic, middle-aged men is associated with a risk for major 
coronary events whereas it is much less predictive among young adults and 
middle-aged or older women (NCEP, 2002). 
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2. Outlook 
 
The aim of this meta-analysis was to provide an overview on the influence of 
gender, ethnicity and socioeconomic status on the occurrence of the first 
cardiovascular event, occurrence of recurrent events and long term and short term 
mortality rates after a cardiovascular event. Furthermore the prevalence of 
cardiovascular risk factors like hypertension, diabetes, hyperlipidemia, obesity and 
smoking among a cohort of CVD patients and in cross-sectional analysis of a 
healthy population should be analysed. It should be elucidated if women are 
significantly older than men at the incidence of the first cardiovascular event and if 
they have more cardiovascular risk factors and a higher mortality rate as it was 
found out in previous literature reviews. Furthermore the influence of ethnicity and 
the socioeconomic status on the prevalence of cardiovascular risk factors, events 
and on the mortality rate should be analysed and differentiated between men and 
women.  
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3. Methods 
 
3.1 Methods for determining the prevalence of cardiovascular diseases 
 
Differently designed studies were used to investigate the prevalence of 
cardiovascular diseases. In the first group of studies a cohort which was already 
affected by a cardiovascular event or a preclinical stage was investigated. These 
studies were either performed as prospective study with patients admitted to 
hospital (Bowker et al, 2000; Goto et al, 2007) or retrospective studies with 
registers or hospital charts that recorded information on CVD events and mortality 
(Smeeton et al, 2007; Gupta et al, 2002). In the second group of studies a cross 
sectional analysis was performed which means collection of data at a certain time 
point within a healthy population (Meigs et al, 2003; MacFadden et al, 2008). In 
this case the prevalence of cardiovascular risk factor and the occurrence of 
cardiovascular events over a certain follow-up period were evaluated. 
 
3.2 Literature search 
 
3.2.1 Identification of relevant trials 
 
In the Pubmed database (www.ncbi.nlm.nih.gov/entrez) literature was screened to 
identify relevant trials which analysed gender, ethnic or socioeconomic differences 
between occurrence of cardiovascular event, mortality rates or prevalence of 
cardiovascular risk factors and their influence on developing cardiovascular 
diseases. Animal studies were excluded. Only abstracts for studies published 
between 1995 and 2009 in English or German were read for further decision of 
inclusion.  
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The following terms were utilised to find relevant trials: 
• “cardiovascular disease/ stroke/ myocardial infarct” and “gender/ 
gender differences” 
• “cardiovascular disease/ stroke/ myocardial infarct” and 
“socioeconomic status/ social differences” 
• “cardiovascular disease/ stroke/ myocardial infarct” and “ethnicity/ 
ethnic differences” 
 
3.2.2 Inclusion criteria 
 
The initial search strategies identified more than 10,000 abstracts with each of the 
word combinations. To be included in the meta-analysis, studies had to satisfy the 
following inclusion criteria: 
 
1) human trial 
2) listing information about any defined outcome like cardiovascular risk 
factors, age, morbidity or mortality rate in at least two different subject 
groups (different gender, ethnicity or SES) 
3) hospitalised or former hospitalised patients with a CVD or patients with high 
progression of arteriosclerosis (or 4) 
4) cross sectional analysis of cardiovascular risk factors and prevalence of 
cardiovascular events 
5) performance period of the study mainly after 1990 
6) study with an adult cohort, preferably older subjects (>30 years) and not 
with children or adolescents 
7) no studies with further selection criteria of the cohort like inclusion of p. ex. 
only hyperlipidemic subjects, only hypertensive subjects 
8) more than 200 subjects 
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3.2.3 Definition of outcomes 
The cardiovascular outcomes of interest included were the following: myocardial 
infarct, stroke, angina pectoris, atrial fibrillation or progression of arteriosclerosis. 
Information on age at the cardiovascular incidence and cardiovascular risk factors 
like hypertension, diabetes, dyslipidemia, obesity, mean BMI or smoking also were 
evaluated in the meta-analysis. Further consequences of cardiovascular diseases 
such as recurrent cardiovascular events, in-hospital mortality rate, short-term or 
long-term mortality rates were also evaluated if mentioned in the included studies. 
The criteria of metabolic syndrome were heterogeneous, some studies used 
ATPIII criteria (NCEP, 2002) or ATP II criteria (NCEP, 1994) (p.ex. Kawamoto et 
al, 2007; Lee et al, 2000) and other studies used WHO criteria (p.ex. Marcus et al, 
2007; Sodjinou et al, 2008). As criteria within a study were equal, results within a 
study could be compared, but not results from various studies. 
 
3.3 Evaluation of results 
 
The studies were divided into two different types of studies (see 4.1): study with a 
cohort already affected by CVD and cross sectional analysis of a primarily healthy 
population. These studies were further divided into studies dealing with gender, 
socioeconomic or ethnic differences in CVD morbidity. 
Data about age of patients, prevalence of the cardiovascular risk factors 
hypertension, diabetes, hyper-or dyslipidemia, obesity, mean BMI, smoking rate, 
in-hospital mortality, 28 to 30 days mortality, 1-year mortality, long-term mortality 
(2-7 years), recurrent events in study cohorts with CVD were sorted in a table. 
Data about the prevalence of cardiovascular risk factors like hypertension, 
diabetes, hyper-or dyslipidemia, obesity, mean BMI, smoking rate, the prevalence 
of CVD (stroke or myocardial infarct) or a fatal event caused by CVDs from 
preliminary healthy cohort were also sorted in a table. All information was sorted 
by gender, socioeconomic status or ethnicity. The associations of gender, ethnicity 
or SES on the prevalence of risk factors and the cardiovascular morbidity and 
mortality in healthy subjects or patients were presented in individual graphs (see 
results section). 
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4. Results 
 
4.1 Literature search 
  
In a literature search with the terms “cardiovascular disease/stroke/myocardial 
infarct” and “gender/gender differences” 70 studies which fulfilled the inclusion 
criteria could be found. With the terms “cardiovascular disease/stroke/myocardial 
infarct” and “social differences/socioeconomic status/ethnicity“ 30 studies that 
investigated the influence of socioeconomic status or ethnicity on the prevalence 
and outcome of cardiovascular diseases were found. From these 30 studies 13 
analysed socioeconomic differences and 17 analysed ethnic differences. From 
these studies 11 studies dealt with gender and socioeconomic differences 
simultaneously and another 10 studies dealt with gender and ethnic differences 
simultaneously.  
The 78 studies which were included in the meta-analysis and their characteristics 
like location of the study, sample size, study design, time period, inclusion criteria 
for subjects, variables, investigated outcome and main results are listed in table1. 
53 out of 78 studies analysed a cohort that was already affected by a 
cardiovascular disease or a preclinical stage. In these studies inclusion criteria 
was acute coronary syndrome in 41 studies, stroke in 10 studies and atrial 
fibrillation in two studies.  
25 out of 78 studies were cross sectional analysis that evaluated the prevalence of 
risk factors and the occurrence of cardiovascular morbidity and/or mortality over a 
certain time period. These two categories of studies were evaluated in separate 
analysis. The studies were divided into studies dealing with gender, ethnic or 
socioeconomic influences. The socioeconomic influences were further evaluated 
according to educational status, occupational status, marital status, residency or 
general socioeconomic status. 
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Table1: Studies included in the meta-analysis 
 
Reference Country Sample 
size (n) 
Study 
design 
Time 
period 
Inclusion criteria  
for subjects 
Variables Outcomes 
investigated 
Main results 
Abdul-Rahim 
et al, 2001 
West Bank 
 
992 cross-
sectional 
study 
1996-
1998 
 
gender, urban-
rural residency 
risk factors 
 
Dyslipidemia and overall 
obesity were more 
prevalent in the urban 
population. 
Aguado-
Romeo 
et al, 2007 
Spain 46007 retrospective 
study 
2000-
2003 
acute coronary 
syndrome 
gender mortality Mortality rate in women 
was higher even after 
adjusting for age and 
comorbidities. 
Alfredsson et 
al, 2007 
Sweden 53781 prospective 
study 
1998-
2002 
non-ST-elevation 
coronary syndrome 
gender risk factors, 
mortality 
Women were older, had 
more likely hypertension 
and diabetes; age 
adjusted mortality did not 
differ significantly. 
Berger et al,  
2006 
USA 4284 prospective 
study 
1998-
1999 
percutaneous 
coronary 
intervention 
gender risk factors, 
mortality 
Women were older, had a 
higher prevalence of 
diabetes and hyper-
tension and a higher 
unadjusted mortality rate. 
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Bouguerra et 
al, 2006 
Tunisia 2927 cross-
sectional 
study 
1995-
1996 
 
gender risk factors 
 
 
The prevalence of 
metabolic syndrome was 
higher among women and 
urban residents and 
increased with age.  
Bowker et al,  
2000 
UK 1064 prospective 
study 
1995-
1996 
myocardial infarct 
or myocardial 
ischemia 
gender age,  
risk factor, 
mortality 
Women with acute 
coronary syndrome were 
older and suffered from 
more comorbidities. 
Bravata  
et al, 2005 
USA 11163 cross-
sectional 
study 
  
 
ethnicity, gender stroke risk 
factors 
Blacks had a higher 
prevalence of hyper-
tension, diabetes and 
higher C-reactive protein 
levels; whites had lower 
HDL levels. 
Chang et al,  
2003 
Canada 22967 retrospective 
study 
1993-
2000 
  
acute myocardial 
infarct 
gender risk factors, 
mortality 
Women were older, had 
more comorbidities and 
higher mortality rates. 
 
8441 unstable angina 
Cheng et al,  
2004 
Taiwan 1032 prospective 
study 
1993-
2002 
acute myocardial 
infarct  
gender risk factors, 
mortality 
Women were older and 
had more often hyper-
tension and diabetes.  
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Dagres et al,  
2007 
Europe 5333 prospective 
study 
2004-
2005 
atrial fibrillation gender risk factors Women were older and 
had a higher rate of 
comorbidities. 
Deurenberg-
Yap  
et al, 2001 
Singapore 4723 cross-
sectional 
study 
1998   ethnicity, gender risk factors The risk factor profile 
differed with ethnicity and 
was less among Chinese. 
Dragano et al, 
2007 
Germany 11554 cross-
sectional 
study 
2000-
2003 
 
Socioeconomic 
status 
risk factors Smoking and obesity 
were more common in 
deprived neighbourhoods 
in Germany; in the Czech 
Republic associations 
were only observed for 
smoking. 
European 
Group for the 
study of 
Insulin 
Resistance 
(EGIR), 2002 
Europe 17563 cross-
sectional 
study 
1990-
1997 
 
gender risk factors The prevalence of 
metabolic syndrome 
increased with age and 
was higher among men at 
a given age. 
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Elkoustaf  
et al,  
2006 
USA 1197 retrospective 
study 
2001-
2004 
non-ST-elevation 
coronary syndrome 
gender risk factors, 
mortality 
Women were older, had 
more often hypertension 
and obesity; in-hospital 
mortality rate did not differ 
between sexes. 
Engström  
et al,  
2001 
Sweden 3540 prospective 
study 
1989-
1998 
stroke socio-economic 
status, gender 
risk factors, 
stroke 
prevalence 
The prevalence of stroke 
was higher among people 
with low socioeconomic 
status. 
Fabijanic  
et al, 2006 
Croatia 3382 prospective 
study 
1990-
1999 
myocardial infarct gender risk factors, 
mortality 
Women with myocardial 
infarct were older, had 
more comorbidities and a 
higher unadjusted 
mortality rate. 
Freedman et 
al, 2005 
USA 1180 cross-
sectional 
study 
    gender, ethnicity risk factors In families enriched for 
members with type 2 
diabetes, African 
American had higher 
carotid artery intima 
media thickness and 
conventional risk factors 
than whites. 
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Galobardes et 
al, 2003 
Switzerland 8194 cross-
sectional 
study 
1993-
2000 
  occupational 
level, gender 
risk factors Smoking, obesity and 
high blood pressure were 
more prevalent among 
persons with low 
socioeconomic position. 
Gargano et 
al, 2007 
USA 373 prospective 
study 
  stroke survivors gender quality of life, 
risk factors 
Women patients were 
older and had a higher 
prevalence of diabetes 
and hypertension; women 
stroke survivors had a 
lower recovery and a 
poorer quality of life. 
Gargano et 
al, 2008 
USA 2566 prospective 
study 
2002 acute stroke or 
transient ischemic 
attack 
gender risk factors, 
mortality 
Women were older and 
more likely had 
hypertension.  
Gerber et al,  
2006 
USA 1104 prospective 
study 
1990-
1998 
myocardial infarct gender risk factors, 
recurrent 
events 
Women were older, had 
more comorbidities and 
had more recurrent 
events. 
Gerward et al,  
2006 
Sweden 5533 prospective 
study 
1996-
2005 
acute myocardial 
infarct 
gender, socio-
economic status 
mortality Rates of survival from 
myocardial infarct were 
inversely related to 
socioeconomic status.  
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Glaser et al,  
2006 
USA 3462 prospective 
study 
1997-
2002 
coronary syndrome gender risk factors, 
mortality 
Women were older, had 
more comorbidities and 
had a higher one-year 
mortality rate.    1457 prospective 
study 
1997-
2003 
stable angina gender risk factors, 
mortality 
Goto et al,  
2007 
Japan 720 prospective 
study 
1995-
2004 
stroke after 
coronary artery 
bypass 
gender age, risk 
factor 
Women were older and 
had higher rates of 
hypertension; men had 
higher rates of 
hyperlipidemia. 
Griffith et al,  
2005 
UK 698 prospective 
study 
1994-
2000 
myocardial infarct gender risk factors, 
mortality 
Women were older and 
had more likely 
hypertension and 
diabetes; mortality was 
higher among women. 
Gupta et al,  
2002 
Canada 1106 retrospective 
study 
1994-
1999 
acute myocardial 
infarct 
country origin risk factors, 
mortality, 
recurrent 
events 
The mortality rate after 
myocardial infarct was 
similar between South 
Asians and non-South 
Asians; South Asians had 
a lower BMI, more likely 
diabetes and less likely 
hyperlipidemia 
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Hajat et al,  
2001 
UK 1198 prospective 
study 
1995-
1998 
stroke ethnicity risk factors The prevalence of 
diabetes and 
hypertension was higher 
among black than white 
stroke patients. 
Harwell et al,  
2005 
USA and 
 Canada 
  cross-
sectional 
study 
1996-
2000 
 
ethnicity, gender heart disease 
and stroke 
death 
The mortality rate from 
cardiovascular diseases 
was higher in Indians 
than in whites. 
Heer et al,  
2006 
Germany 6358 prospective 
study 
2000-
2002 
non-ST-elevation 
coronary syndrome 
gender risk factors, 
mortality 
Women were older, had 
more comorbidities; there 
was no difference in age-
adjusted mortality. 
Hirakawa et 
al, 2006 
Japan 1336 retrospective 
study 
1995-
1997 
acute myocardial 
infarct 
gender risk factors, 
mortality 
Women were older, had 
more comorbidities and a 
higher in-hospital 
mortality rate. 
Hirakawa et 
al, 2007 
 Japan 2614 prospective 
study 
2001-
2003 
acute myocardial 
infarct, undergoing 
percutaneous 
coronary 
intervention 
gender risk factors, 
mortality 
Women were older and 
had higher rates of 
hypertension and in-
hospital mortality; after 
adjusting for age, rate did 
not differ significantly. 
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Hochmann et 
al, 1997 
USA 1473 prospective 
study 
  acute coronary 
syndrome 
gender risk factors Women were older and 
had a higher incidence of 
diabetes and hyper-
tension. 
Hochmann et 
al, 1999 
New 
Zealand, 
Australia,  
USA,  
Belgium 
12142 prospective 
study 
 
acute myocardial 
infarct with or 
without ST-
elevation, unstalbe 
angina 
gender risk factors, 
mortality 
Women were older than 
men and had higher rates 
of diabetes, hypertension, 
and a higher 30 days-
mortality rate.  
Holroyd-
Leduc,  
2000 
Canada 44832 retrospective 
study 
1993-
1996 
acute stroke gender risk factors, 
mortality 
Male stroke patients were 
more likely to suffer from 
diabetes, female patients 
were more likely to suffer 
from hypertension; the 
one year mortality rate 
was lower in women.  
Ikeda et al, 
2007 
Japan 94062 cross-
sectional 
study 
1988-
1999 
 
gender, marital 
status 
risk factors, 
incidence of 
CVD 
Single status was 
associated with a higher 
mortality rate from CVD in 
both sexes; divorce and 
widowhood elevated the 
mortality rate only in men. 
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Kapral et al,  
2002 
Canada 38945 retrospective 
study 
1994-
1997 
stroke gender 
socioeconomic 
differences 
risk factors, 
mortality 
Mortality decreased with 
higher socioeconomic 
status; diabetes was 
more and hypertension 
less prevalent among 
lower socioeconomic 
groups. 
Kaul et al,  
2005 
Canada 1871 prospective 
study 
1998-
2001 
coronary artery 
disease; 
undergoing cardiac 
catherizaiton 
ethnicity, gender risk factors Among blacks there was 
a higher incidence of 
hypertension and 
diabetes. 
Kawamoto et 
al, 2007 
Japan 868 cross-
sectional 
study 
1996-
2006 
  gender intima media 
thickness, 
risk factors 
The intima media 
thickness was 
significantly higher in 
patients with metabolic 
syndrome 
Koek et al,  
2006 
Netherland 21565 retrospective 
study 
1995 acute myocardial 
infarct 
gender mortality Women were older, had a 
higher prevalence of 
diabetes; mortality was 
higher in women; age 
adjusted 28-day mortality 
was equal and 5 years 
mortality was reversed. 
36 
 
Koek et al,  
2007 
Netherland 2018 retrospective 
study 
1999-
2004 
myocardial infarct + 
diabetes 
gender mortality  
(28 days,  
5 years)  
Patients simultaneously 
suffering from myocardial 
infarct and diabetes have 
a higher short-time and 
long-time mortality risk. 
 
  19547     myocardial infarct     
Kuper et al,  
2007 
UK 49259 cross-
sectional 
study 
1991-
2002 
 
education risk factor, 
incidence of 
stroke 
There was a strong 
gradient in risk of stroke 
by years of education. 
Lee et al,  
2000 
Taiwan 3602 cross-
sectional 
study 
1990-
1995 
cardiovascular 
diseases 
gender risk factors White-collar workers 
more likely had 
dyslipidemia and diabetes 
and had a slightly lower 
risk for stroke and sudden 
death. The risk of sudden 
death was higher for men 
than for women. 
Lundblad et 
al, 2008 
Sweden 11763 retrospective 
study 
1985-
2004 
myocardial events gender myocardial 
infarct, 28d- 
mortality 
The proportion of events 
in men to women was 3:1 
in 2004. 
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MacFadden 
et al, 2008 
UK 22486 cross-
sectional 
study 
1993-
2006 
myocardial infarct gender, age mortality, risk 
factors 
Social status was 
associated with higher 
incidence of CVDs, which 
was decreased after 
adjusting for smoking; the 
effect of SES was higher 
in men. 
MacIntyre et 
al, 2001 
UK 201114 retrospective 
study 
1986-
1995 
myocardial infarct gender, age mortality,  
risk factors 
Men had a lower 30-day 
mortality rate, but were 
more likely to die before 
hospitalisation. 
Maksimovic 
et al, 2008 
Serbia 657 prospective 
study 
2006-
2007 
carotid 
atherosclerotic 
disease 
gender, SES risk factors Low and medium 
educational level was 
associated with increased 
triglycerides and CRP 
levels. 
Markus et al,  
2007 
UK 1200 prospective 
study 
1999-
2005 
stroke including 
recurrent stroke 
ethnicity prevalence of 
stroke,  
risk factors 
Black stroke patients 
were younger and had a 
higher prevalence of risk 
factors. 
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Matsui et al,  
2002 
Japan 482 retrospective 
study 
1995-
1996 
acute myocardial 
infarct 
gender risk factors, 
mortality 
Women were older, had a 
higher prevalence of 
diabetes and hyper-
tension and a higher 
mortality rate. 
Meigs et al, 
2003 
USA 5961 
 
cross-
sectional 
study 
1991-
1996 
 
gender, ethnicity risk factors Mexican Americans had a 
higher prevalence of risk 
factors, especially 
women. 
Mendez et al, 
2003 
Jamaica 2082 cross-
sectional 
study 
1993-
1998 
 
gender, 
socioeconomic 
status 
risk factors The prevalence of obesity 
and hypertension was 
higher in women. 
Milcent et al,  
2007 
France 74389 retrospective 
study 
1999 myocardial infarct gender   Women were older and 
had a higher rate of in-
hospital mortality. 
Misra et al, 
2001 
India 532 cross-
sectional 
study 
1998 
 
gender risk factors The prevalence of 
cardiovascular risk factors 
was high in an urban 
slum population of Dehli 
with nearly no gender 
differences. 
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Ordunez et al,  
2005 
Cuba 1667 cross-
sectional 
study 
2001-
2002 
 
gender, ethnicity risk factors There was no difference 
in blood pressure in men 
from different ethnicity; 
women with a lower 
educational level had an 
increased CVD risk. 
Perers et al,  
2005 
Sweden 1744 prospective 
study 
1995-
1999 
acute coronary 
syndrome 
gender risk factors, 
mortality 
Women were older, had 
more comorbidities and 
had slightly higher in-
hospital mortality. 
Pitsavos et al, 
2003 
Greece 3042 cross-
sectional 
study 
2001-
2002 
 
gender risk factors The prevalence of 
cardiovascular risk factors 
was higher among men. 
Qureshi  
et al,  
2006 
USA  547 prospective 
study 
2002 stroke ethnicity, gender risk factors, 
mortality 
African American women 
had the highest mortality 
rate after stroke 
Radovanovic 
et al, 2007 
Switzerland 20290 prospective 
study 
1997-
2006 
acute coronary 
syndrome 
gender risk factors, 
mortality 
Women were older, had 
more comorbidities and a 
higher mortality rate. 
Reina et al,  
2007 
Spain 6209 prospective 
study 
2000-
2001 
myocardial infarct gender risk factors, 
mortality 
Women were older, had 
more comorbidities and a 
higher mortality rate. 
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Rosvall et al,  
2000 
Sweden 4176 cross-
sectional 
study 
1992-
1994 
 
socioeconomic 
status, gender 
risk factors, 
carotid IMT 
An association of 
educational level, 
occupational status, and 
thicker IMT in women and 
low occupational status 
with a thicker IMT in men 
was found. 
Sanderson et 
al, 2007 
USA 616 retrospective 
study 
1996-
2006 
cardiac 
rehabilitation 
ethnicity risk factors Blacks had a higher 
prevalence of risk factors. 
Santos et al, 
2008 
Portugal 1962 cross-
sectional 
study 
  
socioeconomic 
status, gender 
risk factors Metabolic syndrome was 
more frequent in women 
and the prevalence 
increased with low social 
class in women but not 
significantly in men. 
Schreiner  
et al, 2001 
Finland 4900 retrospective 
study 
1983-
1992 
coronary events gender risk factors, 
recurrent 
events 
Men were far more likely 
to have a fatal recurrent 
event than women; 
women had a higher 
prevalence of risk factors. 
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Setoguchi  
et al,  
2008 
USA 1625 retrospective 
study 
2000-
2001 
myocardial infarct gender risk factors, 
mortality 
Women with MI were 
older, had a higher BMI 
and diabetes prevalence; 
men suffered from a 
higher mortality rate. 
Shaw et al,  
2008 
USA 375886 prospective 
study 
2000-
2002 
stable angina; 
elective, diagnostic 
coronary 
angiography 
gender and 
ethnicity 
prevalence of 
acute 
coronary 
syndrome, 
risk factors, 
in-hospital 
mortality 
Blacks had the highest 
prevalence of 
hypertension; Asians had 
the highest prevalence of 
hyperlipidemia; native 
Americans had the 
highest prevalence of 
diabetes; in-hospital 
mortality rate was highest 
among native Americans 
and Asians.  
 
  450329 prospective 
study 
2000-
2002 
acute myocardial 
infarct or unstable 
angina 
gender and 
ethnicity 
risk factors, 
age 
Shen et al,  
2007 
USA 18867 retrospective 
study 
1995-
2000 
atrial fribrillation ethnicity risk factors, 
coronary heart 
disease  
Blacks had the highest 
prevalence of risk factors. 
Singh et al,  
2008 
USA 10981 retrospective 
study 
1996-
2004 
PCI; myocardial 
infarct or unstable 
angina 
gender risk factors, 
mortality rate,  
recurrent CVD 
There was no gender 
difference in 30 days or 1 
year mortality rate. 
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Singh-
Manoux  
et al, 2008 
France 5363 prospective 
study 
1991-
2004 
coronary heart 
disease 
social status risk factor, 
incidence of 
CVDs 
Low SES was associated 
with more risk factors and 
a higher prevalence of 
coronary heart diseases.  
Slater et al,  
2003 
USA 4617 prospective 
study 
  percutaneous 
coronary 
intervention 
ethnicity risk factors, 
mortality 
Blacks, Hispanics and 
Asians were younger than 
whites when undergoing 
PCI and had a higher 
prevalence of risk factors.  
Smeeton et 
al, 2007 
UK 566 retrospective 
study 
1995-
2004 
stroke  ethnicity risk factors White stroke patients 
were older and smoked 
more often; blacks had a 
higher prevalence of 
cardiovascular risk 
factors. 
Sodjinou et 
al, 2008 
Benin 200 cross-
sectional 
study 
  
gender risk factors Female sex and urban 
residency was positively 
associated with 
cardiovascular risk 
factors. 
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Theres et al,  
2004 
Germany 5133 retrospective 
study 
1999-
2002 
acute myocardial 
infarct 
gender risk factors, 
mortality 
Women were older, had 
more likely diabetes and 
hypertension and a higher 
in-hospital mortality rates. 
Thursten  
et al, 2005 
USA 6913 cross-
sectional 
study 
1971-
1993 
  gender risk factors, 
coronary heart 
disease 
events 
The incidence of coronary 
heart disease was higher 
among men; 
cardiovascular risk factors 
were more prevalent 
among women 
U.K. 
Prospective 
Diabetes 
Study Group, 
1998 
UK 4974 prospective 
study 
1977-
1991 
diabetes gender ethnicity, 
gender 
Afro-Caribbean subjects 
with diabetes had a lower 
risk for MI than whites, 
whereas South Asians did 
not have a risk different 
from that of whites. 
Vaccarino et 
al, 2003 
USA 1113 prospective 
study 
1999-
2001 
patients undergoing 
a coronary artery 
bypass graft 
gender risk factors, 
mortality 
Women were older and 
had more risk factors. 
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Venketa-
subramanian 
et al, 2005 
Singapore 14903 cross-
sectional 
study 
2001-
2003 
  ethnicity, gender stroke 
prevalence 
Stroke was most 
prevalent among Chinese 
men and lowest among 
Malay women. 
Victor et al, 
2004 
USA 2971 cross-
sectional 
study 
2000-
2002 
 
gender, ethnicity risk factors Cardiovascular risk 
factors were most 
frequent among black 
women. 
Xu et al, 2008 China 29340 cross-
sectional 
study 
2000-
2001 
 
gender, 
socioeconomic 
status 
risk factors, 
stroke 
prevalence 
An elevated prevalence of 
stroke was associated 
with an increasing level of 
socioeconomic status like 
family average income. 
Zaliunas et al, 
2008 
Lithuania 2756 prospective 
study 
2000-
2005 
patients with 
myocardial infarct 
or unstable angina 
gender risk factors Men more often had 
increased triglyceride 
concentrations and 
women more often had 
too low HDL levels. 
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4.2 Gender and cardiovascular diseases 
 
The number of male patients who were affected by a cardiovascular event or a 
subclinical atherosclerotic stage was higher in 41 studies (Figure 1) (Aguado-
Romeo et al, 2007; Alfredsson et al, 2006; Berger et al, 2006; Chang et al, 2003; 
Cheng et al, 2004; Dagres et al, 2007; Elkoustaf et al, 2006; Engström et al, 2001;  
Fabijanik et al, 2005; Gerber et al, 2006; Glaser et al, 2005; Griffith et al, 2002; 
Gupta et al, 2002; Hajat et al, 2001; Heer et al, 2006; Hirakawa et al, 2006; 
Hirakawa et al, 2007; Hochmann et al, 1997; Hochmann et al, 1999; Kapral et al, 
2002; Kaul et al, 2005; Koek et al, 2007; Lundblad et al, 2008; MacIntyre et al, 
2002; Matsui et al, 2002; Perers et al, 2005; Qureshi et al, 2005; Radovanovic et 
al, 2007; Reina et al, 2007; Sanderson et al, 2007; Schreiner et al, 2001; 
Setoguchi et al, 2008; Shaw et al, 2008; Shen et al, 2007; Singh et al, 2008; Slater 
et al, 2003; Smeeton et al, 2007; Theres et al, 2004; Vaccarino et al, 2003; 
Zaliiunas et al, 2008) and the number of female patients was higher in five studies 
(Figure 1) (Bowker et al, 2000; Gargano et al, 2007; Gargano et al, 2008; Holroyd-
Leduc et al, 2000;Setoguchi et al, 2008). In 34 of those studies the inclusion 
criteria was acute coronary syndrome, in 10 studies it was stroke and in 2 studies 
atrial fibrillation. 
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Figure 1: Number of study subjects with a cardiovascular event 
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4.2.1 Gender difference in age at the incidence of a cardiovascular diseases 
 
30 studies listed the mean age of people who suffered from a cardiovascular 
diseases or a subclinical cardiovascular disease. 27 studies analysed subjects 
with any form of acute coronary syndrome (Alfredsson et al, 2006; Berger et al, 
2006; Bowker et al, 2000; Chang et al, 2003; Cheng et al, 2004; Elkoustaf et al, 
2006; Fabijanik et al, 2005; Gerber et al, 2006; Griffith et al, 2002; Heer et al, 
2006; Hirakawa et al, 2006; Hirakawa et al, 2007; Hochmann et al, 1997; 
Hochmann et al, 1999; Koek et al, 2006; Koek et al, 2007; Lundblad et al, 2008; 
MacIntyre et al, 2002; Matsui et al, 2002; Perers et al, 2005; Radovanovic et al, 
2007; Reina et al, 2007; Setoguchi et al, 2008; Shaw et al, 2008; Singh et al, 
2008; Vaccarino et al, 2003; Zaliiunas et al, 2008), two studies analysed stroke 
patients (Gargano et al, 2008; Goto et al, 2007) and one study analysed patients 
with atrial fibrillation (Dagres et al, 2007). In all 30 studies women were older than 
men (Figure 2). The age difference ranged from only one year (Lundbland et al, 
2008) to 9 years (Gerber et al, 2006). 
MacIntyre et al (2002) differentiated between patients who reached hospital alive 
and patients who did not survive to reach hospital admission. In both groups 
women were older than men. The mean age was 64.3 years in men and 71.6 
years in women among patients who were admitted to hospital and 71.1 years in 
men and 77.7 years in women among the patients who died before reaching 
hospital. 
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Figure 2: Age of patients at the incidence of a cardiovascular event 
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Four studies divided the study subjects into age groups (Figure 3). In three studies 
the proportion of men was higher below 50 or 55 years (Gargano et, 2008; Mac 
Intyre et al, 2002; Milcent et al, 2007). One study reported a similar proportion of 
men and women below an age of 45 years (Quresi et al, 2005). In three studies 
the percentage of men in the age group from 55 to 65 years or 45 to 65 years was 
higher (Mac Intyre et al, 2002; Milcent et al, 2007 and Qureshi et al, 2005). Two 
studies reported that between 65 and 75 years the percentage of male and female 
CVD patients was approximately the same (Milcent et al, 2007; Mac Intyre et al). 
Only in one study the proportion of male and female patients was approximately 
the same from 50 to 80 years of age (Gargano et al, 2008). In three studies the 
percentage of the more than 75 and 80 years old CVD patients was higher in 
women than in men (Gargano et al, 2008; MacIntyre et al, 2002; Milcent et al, 
2007; Theres et al, 2004). A greater percentage of women than men had a CVD 
incidence at an age above 65 years in one study (Glaser et al, 2006).  
 
 
Figure 3: Cardiovascular disease patients, sorted by age groups 
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4.2.2 Gender difference in the prevalence of diabetes among CVD patients 
 
33 studies reported the prevalence of diabetes in male and female CVD patients 
(Figure 4). In 29 of the 33 evaluated studies the prevalence of diabetes was higher 
among women (Alfredsson et al, 2006; Berger et al, 2006; Bowker et al, 2000; 
Chang et al, 2003; Cheng et al, 2004; Dagres et a, 2007; Fabijanik et al, 2005; 
Gargano et al, 2007; Gerber et al, 2006; Glaser et al, 2006; Goto et al, 2007; 
Griffith et al, 2005; Heer et al, 2006; Hirakawa et al, 2006; Hochmann et al, 1997; 
Hochmann et al, 1999; Koek et al, 2006; Matsui et al, 2002; Milcent et al, 2007; 
Perers et al, 2005; Qureshi et al, 2005; Radovanovic et al, 2007; Reina et al, 2007; 
Schreiner et al, 2001; Setoguchi et al, 2008; Singh et al, 2008; Theres et al, 2004; 
Vaccarino et al, 2003; Zaliiunas et al, 2008). In two studies the prevalence was 
higher among men (Elkoustaf et al, 2006; Holroyd-Leduc, 2000) and in two studies 
the prevalence in both sexes was approximately the same (Hirakawa et al, 2007; 
Gargano et al, 2008).  
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Figure 4: Prevalence of diabetes among patients with cardiovascular diseases 
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4.2.3 Gender difference in the prevalence of hypertension among CVD 
patients 
 
In figure 5 the prevalence of hypertension among CVD patients is shown. 32 
studies gave information about the prevalence of hypertension in men and women. 
In all studies the prevalence of hypertension was higher among women 
(Alfredsson et al, 2006; Berger et al, 2006; Bowker et al, 2000; Chang et al, 2003; 
Cheng et al, 2004; Dagres et al, 2007; Elkoustaf et al, 2006; Fabijanik et al, 2005; 
Gargano et al, 2007; Gargano et al, 2008; Gerber et al, 2006; Glaser et al, 2006; 
Goto et al, 2007; Griffith et al, 2005; Heer et al, 2006; Hirakawa et al, 2006; 
Hirakawa et al, 2007; Hochmann et al, 1997; Hochmann et al, 1999; Holroyd-
Leduc et al, 2000; Matsui et al, 2002; Milcent et al, 2007; Perers et al, 2005; 
Qureshi et al, 2005; Radovanovic et al, 2007; Reina et al, 2007; Schreiner et al, 
2001; Setoguchi et al, 2008; Singh et al, 2008; Theres et al, 2004; Vaccarino et al, 
2003; Zaliiunas et al, 2008). In most studies the gender difference was significant, 
only in some studies there was an only slight difference in the prevalence of 
hypertension like the study of Zaliunas et al (2008). 
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Figure 5: Prevalence of hypertension among patients with cardiovascular diseases 
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4.2.4 Gender difference in the prevalence of hyper-/dyslipidemia among 
CVD patients 
 
21 studies reported the prevalence of hyperlipidemia. In nine studies the 
prevalence of hyper- or dyslipidemia was higher among men (Chang et al, 2003; 
Cheng et al, 2004; Gargano et al, 2008; Heer et al, 2006; Hirakawa et al, 2006; 
Qureshi et al, 2005; Radovanovic et al, 2007; Theres et al, 2004; Zaliunas et al, 
2008), whereas in 12 studies the prevalence was higher among women (Elkoustaf 
et al, 2006; Fabijanik et al, 2006; Gerber et al, 2006; Glaser et al, 2006; Goto et al, 
2007; Hirakawa et al, 2007; Hochmann et al, 1999; Matsui et al, 2002; Perers et 
al, 2005; Reina et al, 2007; Singh et al, 2008; Vaccarino et al, 2003) (Figure 6).  
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Figure 6: Prevalence of hyperlipidemia among patients with cardiovascular diseases 
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al, 2003). The mean BMI was slightly higher among women in 2 studies (Berger et 
al, 2006; Schreiner et al, 2001), about the same in one study (Singh et al, 2008) 
and higher among men in one study (Hirakawa et al, 2007). 
 
 
Figure 7: Prevalence of obesity among patients with cardiovascular diseases 
 
 
Figure 8: Mean BMI of patients with cardiovascular diseases 
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al, 2006; Fabijanik et al, 2005; Gargano et al, 2007; Gargano et al, 2008; Gerber 
et al, 2006; Glaser et al, 2006; Goto et al, 2007; Griffith et al, 2005; Heer et al, 
2006; Hirakawa et al, 2006; Hirakawa et al, 2007; Hochmann et al, 1997; 
Hochmann et al, 1999; Matsui et al, 2002; Milcent et al, 2007; Perers et al, 2005; 
Qureshi et al, 2005; Radovanovic et al, 2007; Reina et al, 2007; Schreiner et al, 
2001; Setoguchi et al, 2008; Singh et al, 2008; Theres et al, 2004; Vaccarino et al, 
2003) (Figure 9). Interestingly, the smoking habits differed only slightly in some 
studies of certain European countries or the USA (p. ex. Alfredsson et al, 2006; 
Elkoustaf et al, 2006; Milcent et al, 2007; Singh et al, 2008). In other European 
studies the difference was higher like in the two German studies where more than 
twice as much men were smokers compared to women (Heer et al, 2006; Theres 
et al, 2004). The difference in Europe was highest in the Croatian study (Fabijanik 
et al, 2006), the Spanish study (Reina et al, 2007) and the Finish study (Schreiner 
et al, 2001) with about 3 times more male smokers than female. The highest 
gender difference was found in Asian countries like Taiwan (Cheng et al, 2004) 
where smoking prevalence was about 13 times higher in men than in women and 
Japan where smoking prevalence was 3 to 4 times higher among women than 
among men (Goto et al, 2007; Hirakawa et al, 2006; Hirakawa et al, 2007; Matsui 
et al, 2002).  
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Figure 9: Prevalence of smoking among patients with cardiovascular diseases 
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4.2.7 Gender difference in the prevalence of recurrent events 
 
In two studies the prevalence of recurrent events within 30 days was slightly 
higher in men than in women (Figure 10) (Qureshi et al, 2005; Singh et al, 2008). 
In two other studies the occurrence of recurrent events within one year was higher 
in women (Figure 11) (Gerber et al, 2008; Singh et al, 2008). In the study of Glaser 
et al (2008) recurrent events among stable angina patients were more prevalent in 
women and among coronary syndrome patients more prevalent in men. 
 
 
Figure 10: recurrent events [%] within 30 days among male and female patients with 
cardiovascular diseases 
 
 
Figure 11: recurrent events [%] within one year among male and female patients with 
cardiovascular diseases 
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differentiated according to age groups. In 11 out of 16 studies women had a higher 
in-hospital mortality rate (Aguado-Romeo et al, 2007; Alfredsson et al, 2006; 
Gargano et al, 2008; Heer et al, 2006; Hirakawa et al, 2006; Hirakawa et al, 2007; 
Milcent et al, 2007; Perers et al, 2005; Radovanovic et al, 2007; Singh et al, 2008; 
Theres et al, 2004), in 4 studies men had a higher rate (Bowker et al, 2000; 
Elkoustaf et al, 2006; Fabijanik et al, 2006; Setoguchi et al, 2008) and in one study 
the rate was about the same in both sexese (Berger et al, 2006). Fabijanik et al 
(2006) reported a higher mortality rate among men in patients between 45 and 64 
years and a higher mortality rate among women in patients above 65 years. There 
were nearly no fatal outcomes in patients younger than 45 years.  
Several studies adjusted the in-hospital mortality rate to various variables. As a 
consequence gender difference in in-hospital mortality was diminished in two 
studies after adjustment for age (Milcent et al, 2007; Fabijanik et al, 2006) or other 
baseline factors like hypertension, diabetes, hypercholesterolemia, smoking or the 
AMI type (Fabijanik et al, 2006) or after adjustment for age, comorbidities and 
interventions (Milcent et al, 2007). In seven studies gender difference in in-hospital 
mortality disappeared after adjustment for age (Alfredsson et al, 2006; Heer et al, 
2006; Radovanovic et al, 2007), after adjustment for age, several comorbidities 
and cardiovascular risk factors (Hirakawa et al, 2006; Hirakawa et al, 2007; 
Radovanovic et al, 2007; Theres et al, 2004), after adjustment for selected hospital 
procedures, complications, secondary prevention measures and outcomes 
(Gargano et al, 2008). 
61 
 
 
Figure 12: in-hospital mortality rate [%] among male and female patients with cardiovascular 
diseases 
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the patients younger than 65 years women were affected by a slightly higher 
mortality rate, in all other age groups men had a higher rate. Koek et al (2007) 
evaluated the mortality of patients with a myocardial infarct with and without 
diabetes. Among both groups the mortality was higher in women. Lundblad et al 
(2008) showed the mortality rate of patients with their first myocardial infarct and 
patients with a recurrent infarct which was in both groups higher in men. MacIntyre 
et al (2002) differentiated into subject groups that reached hospital alive or did not. 
In both groups women had the higher mortality rate after 28 days. 
Three studies adjusted the mortality rate to various variables. As a consequence 
gender differences were diminished in one study after adjustment for age and 
various variables (Reina et al, 2007) or disappeared in two studies after 
adjustment for age (Alfredsson et al, 2006) or after adjustment for age, smoking, 
comorbidity, previous vascular diseases, diabetes, hypertension, and social 
deprivation (Griffith et al, 2005). 
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Figure 13: 28/30 day-mortality rate [%] among male and female patients with cardiovascular 
diseases 
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coronary syndrome and a lower mortality rate for men with stable angina. Koek et 
al (2006) found out that the mortality rate of myocardial infarct patients with and 
without diabetes was higher among women. Holroyd-Leduc et al (2000) 
differentiated the mortality rate according to age groups. Mortality rate was higher 
for men in all age groups except for the patients younger than 65 years. 
One study adjusted the one-year-mortality rate to age which was higher in men 
(Alfredsson et al, 2006). 
 
 
Figure 14: 1-year--mortality rate [%] among male and female patients with cardiovascular 
diseases 
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Several studies adjusted the mortality rate to various variables. As a consequence 
gender difference disappeared after adjustment for age, smoking, comorbidities, 
previous vascular disease, diabetes, hypertension, and social deprivation (Griffith 
et al, 2005). In the study of Chang et al (2003) the hazard ratios for 5-years 
mortality in women versus men were 0.81 after unstable angina and 0.99 after 
acute myocardial infarct after adjustment for baseline characteristics and 
revascularization. In the study of Berger et al (2006) the 3-years-mortality-rate 
adjusted to comorbidities was lower in women than in men. 
 
 
Figure 15: 2-7 year-mortality rate [%] among male and female patients with cardiovascular 
diseases 
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4.3 Ethnicity and cardiovascular diseases 
 
11 studies analysed the characteristics of people with cardiovascular diseases 
depending on ethnicity.  
 
4.3.1 Ethnicity and difference in age of CVD patients 
 
Nine studies gave information on the age of CVD patients from different ethnicity 
(Figure 16). In all eight studies which compared age of black and white patients, 
white CVD patients were older than black (Hajat et al, 2002; Kaul et al, 2005; 
Markus et al, 2007; Sanderson et al, 2007; Shaw et al, 2008; Shen et al, 2007; 
Slater et al, 2003; Smeeton et al, 2007). Three of those studies compared stroke 
patients and six compared patients with any form of coronary syndrome or the 
preclinical stage, atrial fibrillation.  
Two studies compared black African and black Caribbean stroke patients. In both 
studies black Caribbean stroke patients were much older (Smeeton et al, 2007; 
Markus et al, 2007).  
Asian CVD patients had a similar age as white CVD patients in two studies (Shaw 
et al, 2008; Gupta et al, 2002) and were younger in two studies (Shen et al, 2007; 
Slater et al, 2003).  
Hispanics were younger than whites and Asians in three studies (Shen et al, 2007; 
Slater et al, 2003; Shaw et al, 2008) and older than blacks in two studies (Slater et 
al, 2003; Shaw et al, 2008), but younger than blacks in one study (Shen et al, 
2007). 
Native American patients with acute coronary syndrome and stable angina were 
younger than whites, Asians, Hispanics and blacks. White, Asian, Hispanic, black 
and Native American women with stable angina were older than men from the 
same ethnicity (Shaw et al, 2008). 
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Figure 16: Age of patients with cardiovascular diseases from different ethnicity 
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One studies sorted stroke patients by age groups (Figure 17). More whites were 
older than 65 years than blacks at incidence of stroke. More women were older 
than 65 years at their first stroke than men among black and white patients 
(Qureshi et al, 2005). 
 
 
Figure 17: Age of patients with cardiovascular diseases from different ethnicity 
 
4.3.2 Ethnicity and prevalence of diabetes among CVD patients 
 
Nine studies analysed the prevalence of diabetes in patients from different 
ethnicity who had a cardiovascular disease (Figure 18). The prevalence of 
diabetes was higher in blacks than in whites in eight studies (Hajat et al, 2002; 
Kaul et al, 2005; Markus et al, 2007; Sanderson et al, 2007; Shaw et al, 2008; 
Shen et al, 2007; Slater et al, 2003; Smeeton et al, 2007). In one study black 
Caribbean had a higher prevalence of diabetes (Markus et al, 2007) and in one 
study black Africans had a higher prevalence (Smeeton et a, 2007). Four studies 
showed a higher occurrence of diabetes in Asians than in whites (Gupta et al, 
2002; Shaw et al, 2008; Shen et al, 2007; Slater et al, 2003). Hispanics had more 
likely diabetes than blacks, Asians and whites as showed in three studies (Shaw et 
al, 2008; Shen et al, 2007; Slater et al, 2003). Among Native Americans diabetes 
was most prevalent (Shaw et al, 2008). 
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Figure 18: Prevalence of diabetes among patients with cardiovascular diseases from 
different ethnicity 
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4.3.3 Ethnicity and prevalence of hypertension among CVD patients 
 
Nine studies analysed the prevalence of hypertension in patients from different 
ethnicity who suffered from a cardiovascular disease (Figure 19). The prevalence 
of hypertension was higher in blacks than in whites as shown in eight studies 
(Hajat et al, 2002; Kaul et al, 2005; Markus et al, 2007; Sanderson et al, 2007; 
Shaw et al, 2008; Shen et al, 2007; Slater et al, 2003; Smeeton et al, 2007). In one 
study black Caribbeans had a higher prevalence of hypertension (Markus et al, 
2007) and in one study black Africans had a higher prevalence (Smeeton et a, 
2007). Hypertension was more prevalent in Asians than in whites as reported by 
four studies (Gupta et al, 2002; Shaw et al, 2008; Shen et al, 2007; Slater et al, 
2003). Hispanics had more likely hypertension than blacks, Asians and whites as 
showed in three studies (Shaw et al, 2008; Shen et al, 2007; Slater et al, 2003). 
Among Native Americans hypertension was most prevalent (Shaw et al, 2008). 
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Figure 19: Prevalence of hypertension among patients with cardiovascular diseases from 
different ethnicity 
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4.3.4 Ethnicity and prevalence of hyper-/dyslipidemia among CVD patients 
 
Six studies analysed the prevalence of hyper- or dyslipidemia in patients from 
different ethnicity who had a cardiovascular disease (Figure 20). In three studies 
the prevalence of hyper- or dyslipidemia was lower in black than in white patients 
(Kaul et al, 2005; Shaw et al, 2008; Slater et al, 2003), whereas the prevalence 
was about the same in the study of Sanderson et al (2007) and higher than in 
whites in the study of Markus et al (2007). Black Caribbean had a similar 
prevalence hyper- or dyslipidemia as black Africans (Markus et al, 2007). In 
Asians hyper- or dyslipidemia was less prevalent in Asians than in whites as 
reported in one study (Gupta et al, 2002). Shaw et al (2008) showed a higher 
prevalence of hyper- or dyslipidemia among Asian stable angina patients and a 
lower prevalence among acute coronary syndrome patients. Hispanics had more 
likely hyper- or dyslipidemia than blacks and less likely than Asians and whites as 
showed in two studies (Shaw et al, 2008; Slater et al, 2003). Among Native 
Americans hyper- or dyslipidemia was more prevalent than among blacks and 
Hispanics and less prevalent than among Asians and whites (Shaw et al, 2008). 
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Figure 20: Prevalence of hyper-/dyslipidemia among patients with cardiovascular diseases 
from different ethnicity 
 
4.3.5 Ethnicity and prevalence of obesity among CVD patients 
 
Two studies reported the prevalence of obesity among CVD patients (Figure 21). 
In both studies more blacks were obese than whites and more black Caribbean 
were obese than black Africans (Markus et al, 2007). 
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Figure 21: Prevalence of obesity among patients with cardiovascular diseases from different 
ethnicity 
 
Three studies reported the mean BMI of CVD patients (Figure 22). Asian patients 
had the lowest BMI as shown in two studies (Gupta et al, 2002; Shaw et al, 2008). 
Blacks had a higher BMI than whites which was shown in two studies (Kaul et al, 
2005; Shaw et al, 2008). Shaw et al (2008) reported a higher BMI of Hispanics 
compared to Asians and whites and a lower BMI than blacks and Native 
Americans. 
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Figure 22: Mean BMI among patients with cardiovascular diseases from different ethnicity 
 
4.3.6 Ethnicity and prevalence of smoking among CVD patients 
 
Eight studies reported the prevalence of smoking among CVD patients from 
different ethnicity (Figure 23). Four studies showed that more black patients 
smoked than white patients (Kaul et al, 2005; Sanderson et al, 2007; Shaw et al, 
2008; Slater et al, 2003), whereas in three studies less blacks smoked compared 
to whites (Hajat et al, 2001; Markus et al, 2007; Smeeton et al, 2007). In all three 
studies Asians smoked less than whites (Gupta et al, 2002; Shaw et al, 2008; 
Slater et al, 2003). Less Hispanic CVD patients than white and black were 
smokers and more than Asians (Shaw et al, 2008; Slater et al, 2003). Among 
Native American patients with stable angina or coronary syndrome smoking was 
most common compared to patients from other ethnicities (Shaw et al, 2008). 
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Figure 23: Prevalence of smoking among patients with cardiovascular diseases from 
different ethnicity 
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4.3.7 Ethnicity and prevalence of recurrent events 
 
In the study of Qureshi et al (2005) black men had the highest rate of recurrent 
events, followed by white women and white men (Figure 24). Black women had 
the lowest rate. In another study South Asians had a higher rate of recurrent 
events than non South Asians (Gupta et al, 2002). 
 
 
Figure 24: recurrent events within 30 days [%], among patients with cardiovascular diseases 
from different ethnicity 
 
4.3.8 Ethnicity and mortality rate among CVD patients 
 
The in-hospital-mortality rate was evaluated in three studies (Figure 25). In two 
studies black CVD patients had a lower in-hospital-mortality rate than whites, 
which was significant in one study (Slater et al, 2003) and only slightly in the other 
study (Shaw et al, 2008). Asians had a slightly higher in-hospital-mortality rate 
than whites in two studies (Gupta et al, 2002; Shaw et al, 2008) and a slightly 
lower mortality rate than whites in one study (Slater et al, 2003). Hispanics were 
affected by a slightly higher rate than whites in one study (Shaw et al, 2008) and 
by a lower rate in the other study (Slater et al, 2003). Furthermore Hispanics had a 
slightly higher mortality rate than blacks in the two studies and a slightly lower rate 
than Asians (Shaw et al, 2008; Slater et al, 2003). Native Americans with acute 
coronary syndrome had the lowest in-hospital mortality rate compared to whites, 
blacks, Hispanics and Asians (Shaw et al, 2008). 
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Figure 25: In-hospital-mortality rate of patients with cardiovascular diseases from different 
ethnicity 
 
One-year-mortality rate was evaluated in two studies (Figure 26). In one study 
black CVD patients had a slightly lower one-year-mortality rate than white patients 
(Slater et al, 2003). In the other study black women had a higher mortality rate 
than white women, whereas black men had a slightly lower mortality rate than 
white men (Qureshi et al, 2005). Asians had a higher 1-year-mortality rate than 
whites in the studies of Slater et al (2003). In the same study Hispanics were 
affected by a slightly higher rate than whites and blacks and a slightly lower rate 
than Asians (Slater et al, 2003).  
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Figure 26: 1-year-mortality rate of patients with cardiovascular diseases from different 
ethnicity 
 
The two-years-mortality rate was only evaluated by one study (Figure 27) (Slater 
et al, 2003). Asians were affected by the lowest rate and blacks by the highest 
rate. Hispanics had a higher two-years mortality rate than whites.  
 
 
Figure 27: 2-years-mortality rate of patients with cardiovascular diseases from different 
ethnicity 
5,2
4,3
6,3
7,6
27
37
25
21
0 5 10 15 20 25 30 35 40
Qureshi et al, 2005: White
Qureshi et al, 2005: Black 
Slater et al, 2003: White 
Slater et al, 2003: Black
Slater et al, 2003: Hispanics
Slater et al, 2003: Asians
1 year-mortality [%]
total
7,9
14,2
9,8
5,1
0 2 4 6 8 10 12 14 16 18 20
Slater et al, 2003: White 
Slater et al, 2003: Black
Slater et al, 2003: Hispanics
Slater et al, 2003: Asians
2 years-mortality [%]
total
80 
 
4.4 Cardiovascular diseases and socioeconomic status 
 
4.4.1 Influence of socioeconomic status on the age of CVD patients 
 
Two studies gave information on age of CVD patients from different 
socioeconomic classes (Figure 28). Age did not differ significantly in one study 
which sorted patients according to income quintile (5=highest income and 
1=lowest income) (Kapral et al, 2002). Among patients sorted by educational level, 
those defined as having “medium educational level” were significantly younger 
(Maksimovic et al, 2008). 
 
 
Figure 28: Age of patients at the incidence of a cardiovascular event 
 
4.4.2 Prevalence of cardiovascular risk factors among patients with CVD 
from different socioeconomic status  
 
The prevalence of diabetes in CVD patients from different SES was evaluated by 
three studies (Figure 29). In the first study the prevalence of diabetes increased 
with lower SES in both sexes. Only among men the prevalence of diabetes was 
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et al, 2001). In the second study the prevalence of diabetes was higher in the 
lower income groups. Interestingly it was similar in the first and the fourth income 
group (Kapral et al, 2002). In the study of Maksimovic et al (2008) medium 
educational level was associated with the highest diabetes rate. 
 
 
Figure 29: Prevalence of diabetes among patients with cardiovascular diseases from 
different socioeconomic status 
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prevalence of hypertension. In the third study the prevalence of hypertension is 
more prevalent among patients with low educational level compared to patients 
with a medium or a high level (Maksimovic et al, 2008). 
 
 
Figure 30: Prevalence of hypertension among patients with cardiovascular diseases from 
different socioeconomic status 
 
The prevalence of hyper-or dyslipidemia was only evaluated in one study where 
patients with a medium educational level had the highest prevalence and those 
with a high educational level had the lowest prevalence (Figuer 31) (Maksimovic et 
al, 2008). 
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Figure 31: Prevalence of hyper-/dyslipidemia among patients with cardiovascular diseases 
from different socioeconomic status 
 
The prevalence of obesity was evaluated in three studies (Figure 32). In all three 
studies the prevalence of obesity was highest in the lowest social class which was 
defined by SES or income level in two studies and educational level in one study 
(Engström et al, 2001; Kapral et, 2002; Maksimovic et al, 2008). Interestingly, 
patients with a medium educational level had a lower prevalence of obesity than 
patients with high educational level (Maksimovic et al, 2008). In the study of 
Engström et al (2001), women from medium SES had a lower occurrence of 
obesity than women from high SES. 
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Figure 32: Prevalence of obesity among patients with cardiovascular diseases from different 
socioeconomic status 
 
Two studies reported the prevalence of smoking among CVD patients from 
different socioeconomic status (Figure 33). In one study which divided patients into 
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rate among patients with medium educational level (Maksimovic et al, 2008). 
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Figure 33: Prevalence of smoking among patients with cardiovascular diseases from 
different socioeconomic status 
 
4.4.3 Mortality rate among patients with CVD from different socioeconomic 
status  
 
The 28 or 30 days mortality rate was higher in lower socioeconomic groups as 
reported by two studies (Figure 34) (Gerward et al, 2006; Kapral et al, 2002). 
Exceptions were female patients from middle SES which had a lower mortality rate 
than female patients from high or low SES. In the middle SES group women had 
an even lower mortality rate than men, whereas in all other SES groups men had a 
lower rate (Gerward et al, 2006). 
 
25
27
31
22
27
29
29,2
36,1
25,8
0 5 10 15 20 25 30 35 40 45 50
Engström et al, 2001: SES high
Engström et al, 2001: SES medium
Engström et al, 2001: SES low
Maksimovic et al, 2008: educational 
level: high
Maksimovic et al, 2008: educational 
level: medium
Maksimovic et al, 2008: educational 
level: low
Prevalence of smoking [%]
men women total
86 
 
 
Figure 34: 28/30 days mortality rate among patients with cardiovascular diseases from 
different socioeconomic status 
 
The 1-year-mortality rate was reported by only one study in which it was 
significantly higher in the lowest income group compared to the highest income 
group (Figure 35) (Kapral et al, 2002). 
 
 
Figure 35: 1-year-mortality rate among patients with cardiovascular diseases from different 
socioeconomic status 
 
15,4
20,9
26,6
23,1
20,7
27,5
17,9
23,4
23,8
17
20
0,0 5,0 10,0 15,0 20,0 25,0 30,0
Gerward et al, 2006: high SES
Gerward et al, 2006: middle SES
Gerward et al, 2006: low SES
Kapral et al, 2002: Income quintile 5
Kapral et al, 2002: Income quintile 1
28/30 days mortality rate [%]
men women total
31
34
0 10 20 30 40 50
Kapral et al, 2002: Income quintile 5
Kapral et al, 2002: Income quintile 1
1 year mortality rate [%]
total
87 
 
4.5 Gender and prevalence of cardiovascular risk factors  
 
4.5.1 Gender difference in prevalence of diabetes 
 
17 studies evaluated the gender difference in the prevalence of diabetes in cross-
sectional analysis (Figure 36). Some studies compared men and women from all 
age groups and some studies sorted according to different age groups. 
In the studies which analysed all age groups, women had a higher occurrence of 
diabetes than men in three studies (Abdul-Rahim et al, 2001; Deurenberg et al, 
2001 and Thursten et al, 2005), the same occurrence as men in one study (Lee et 
al, 2000) and a lower occurrence than men in four studies (Rosvall et al, 2000; 
Sodjinou et al, 2008; Meigs et al, 2003; Pitsavos et al, 2003). The studies with a 
higher prevalence of diabetes among women were performed in West-Bank, 
Singapore and the USA whereas the studies with a higher prevalence among men 
were performed in Europe, USA or Africa. The study with no gender difference in 
occurrence of diabetes was performed in Taiwan.  
In all four studies which investigated a sample younger than 40 years, men had a 
higher prevalence of diabetes than women (DESIR study, Barilla study, MORGEN 
study, VIVA study in EGIR, 2002). In the sample groups aged 40 to 55 years, five 
studies reported a higher diabetes rate among men (DESIR study, Ely study; 
Barilla follow-up study, Barilla study, VIVA study in EGIR et al, 2002), one study 
reported a lower rate (Goodinge study in EGIR, 2002) and one study a similar rate 
(MORGEN study in EGIR, 2002). In a sample group aged more than 55 years in 
five studies men more likely had diabetes than women (DESIR study, Goodinge 
study, Ely study; Glostrup study MORGEN study in EGIR et al, 2002) and in one 
study it was reverse (VIVA study in EGIR, 2002). All those studies with a 
significantly higher prevalence of diabetes among men in all age groups were 
performed in Europe. 
In one study the prevalence of diabetes in different age groups of Tunisian people 
was analysed. This study showed a higher rate of diabetes in men than in women 
aged 20-29 years and 40-49 years and a higher rate in women in all other age 
groups (Bouguerra et al, 2005). 
Generally there was an increase in the prevalence of diabetes with age among 
men and women in all studies. 
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Figure 36: Prevalence of diabetes, depending on gender; the DESIR study, Goodinge study, 
Ely study, Gostrup study, Barilla study, MORGEN study and VIVA study were summarised in 
EGIR et al 2002). 
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4.5.2 Gender difference in prevalence of hypertension 
 
20 studies evaluated the gender difference in the prevalence of hypertension in 
cross-sectional analysis. Some studies compared men and women from all age 
groups and some studies sorted according to different age groups (Figure 37). 
In the studies which summarized all age groups, women more likely had 
hypertension than men in three studies (Lee et al, 2000; Sodjinou et al, 2008; 
Thursten et al, 2005), the same occurrence as men in one study (Abdul-Rahim et 
al, 2001) and a lower occurrence than men in seven studies (Deurenberg-Yap et 
al, 2001; Galobardes et al, 2003; Ordunez et al, 2005; Rosvall et al, 2000; Meigs 
et al, 2003; Pitsavos et al, 2003; Santos et al, 2008). The studies with a higher 
prevalence of hypertension among women were performed in Taiwan, Benin and 
the USA whereas the studies with a higher prevalence among men were 
performed in Singapore, Europe, USA or Cuba. The study with no gender 
difference in occurrence of hypertension was performed in West-Bank.  
In all four European studies which investigated a cohort younger than 40 years, 
men had a higher prevalence of hypertension than women (DESIR study, Barilla 
study, MORGEN study, VIVA study in EGIR, 2002). Five studies reported a higher 
hypertension rate among men in a cohort aged 40 to 55 years, (DESIR study, Ely 
study; Barilla follow-up study, Barilla study, MORGEN study in EGIR et al, 2002), 
one study reported a lower rate (VIVA study in EGIR, 2002) and one study 
reported a similar rate (Goodinge study in EGIR, 2002). Three studies showed that 
in a cohort aged more than 55 years hypertension was more prevalent among 
men than among women (DESIR study, Glostrup study MORGEN study in EGIR 
et al, 2002). In one study the prevalence was similar (Ely study) and in two studies 
the prevalence was higher in women (Goodinge study, VIVA study in EGIR, 2002).  
In one study the prevalence of hypertension in different age groups of Tunisian 
people was investigated. This study showed a higher rate of hypertension in men 
than in women aged 20-29 years and a higher rate in women in all other age 
groups (Bouguerra et al, 2005). 
Generally there was an increase in the prevalence of hypertension with age 
among men and women in all studies. 
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Figure 37: Prevalence of hypertension, depending on gender; the DESIR study, Goodinge 
study, Ely study, Gostrup study, Barilla study, MORGEN study and VIVA study were 
summarised in EGIR et al 2002). 
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4.5.3 Gender difference in prevalence of hyper-/dyslipidemia 
 
18 studies evaluated the gender difference in the prevalence of hyper- or 
dyslipidemia in cross-sectional analysis. Some studies compared men and women 
from all age groups and some studies sorted according to different age groups 
(Figure 38). 
In the studies which analysed all age groups, women had a higher occurrence of 
hyper- or dyslipidemia than men in three studies (Lee et al, 2000; Sodjinou et al, 
2008; Santos et al, 2008) and a lower occurrence than men in six studies 
(Deurenberg-Yap et al, 2001; Galobardes et al, 2003; Meigs et al, 2003; Pitsavos 
et al, 2003; Rosvall et al, 2000; Abdul-Rahim et al, 2001). The studies with a 
higher prevalence of hyper- or dyslipidemia among women were performed in 
Taiwan, Benin and Portugal whereas the studies with a higher prevalence among 
men were performed in Singapore, Europe, USA or Benin.  
In all four European studies which gave information on a cohort younger than 40 
years, men had a higher prevalence of hyper- or dyslipidemia than women (DESIR 
study, Barilla study, MORGEN study, VIVA study in EGIR, 2002). In the subject 
groups aged 40 to 55 years all seven studies reported a higher hyper- or 
dyslipidemia rate among men (DESIR study, Ely study; Barilla follow-up study, 
Barilla study, MORGEN study, VIVA study; Goodinge study in EGIR et al, 2002). 
In four studies in a cohort aged more than 55 years men more likely had hyper- or 
dyslipidemia than women (DESIR study, Glostrup study MORGEN study, VIVA 
study in EGIR et al, 2002), in one study the prevalence was similar (Goodinge 
study) and in one study it was reverse (Ely study in EGIR, 2002). 
In one study the prevalence of hyper- or dyslipidemia in different age groups of 
Tunisian people was analysed. This study showed a higher rate of hyper- or 
dyslipidemia in men than in women aged 30-49 years and a higher rate in women 
in all other age groups (Bouguerra et al, 2005). 
Generally there was an increase in the prevalence of hyper- or dyslipidemia with 
age among men and women in all studies. 
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Figure 38: Prevalence of hyper-/dyslipidemia, depending on gender; the DESIR study, 
Goodinge study, Ely study, Gostrup study, Barilla study, MORGEN study and VIVA study 
were summarised in EGIR et al 2002). 
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4.5.4 Gender difference in prevalence of obesity 
 
17 studies evaluated the gender difference in the prevalence of obesity in cross-
sectional analysis. Some studies compared men and women from all age groups 
and some studies sorted according to different age groups (Figure 39). 
In the studies which analysed all age groups, women had a higher occurrence of 
obesity than men in six studies (Sodjinou et al, 2008; Santos et al, 2008; Meigs et 
al, 2003; Deurenberg-Yap et al, 2001; Ordunez et al, 2005; Abdul-Rahim et al, 
2001) and a lower occurrence than men in two studies (Galobardes et al, 2003; 
Pitsavos et al, 2003). The studies with a higher prevalence of obesity in men were 
performed in Europe and the studies with a higher prevalence in women were 
performed in Benin, Europe, USA, Singapore, Cuba, Tunisia and West-Bank.  
In three European studies which investigated a subject group younger than 40 
years, men had a higher prevalence of obesity than women (DESIR study, 
MORGEN study, VIVA study in EGIR, 2002) and in one study women had a higher 
prevalence of obesity than men (Barilla study in EGIR, 2002). In the subject 
groups aged 40 to 55 years four studies reported a higher obesity rate among men 
(DESIR study, MORGEN study, Ely study, VIVA study in EGIR et al, 2002) and 
three studies a higher obesity rate among women (Goodinge study, Barilla study, 
Barilla follow-up study in EGIR et al, 2002). In a sample group aged more than 55 
years in four studies men more likely had obesity than women (DESIR study, Eli 
study, MORGEN study, VIVA study in EGIR et al, 2002) whereas in one study it 
was reverse (Goodinge study in EGIR, 2002).  
In one study the prevalence of obesity in different age groups of Tunisian people 
was analysed. This study showed a higher rate of obesity in women in all age 
groups (Bouguerra et al, 2005). 
Generally there was a trend of increasing prevalence of obesity with age among 
men and women in all studies. 
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Figure 39: Prevalence of obesity, depending on gender; the DESIR study, Goodinge study, 
Ely study, Gostrup study, Barilla study, MORGEN study and VIVA study were summarized in 
EGIR et al 2002). 
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The mean BMI of both sexes was reported in seven studies (Figure 40). In five of 
them a higher BMI was found among men (Deurenberg et al, 2001; Galobardes et 
al, 2003; Pitsavos et al, 2003; Rosvall et al, 2000; Thursten et al, 2005) whereas 
only in two studies women had a higher BMI than men (Lee et al, 2000; Ordunez 
et al, 2005). These two studies were performed in Taiwan and Cuba whereas the 
studies with a higher male BMI were performed in Europe, in the USA or 
Singapore. The mean BMI of women in the study performed in Benin is higher 
than the BMI of all men and women of the other studies (Sodjinou et al, 2008). 
 
 
Figure 40: Mean BMI, depending on gender 
 
4.5.5 Gender difference in prevalence of smoking 
 
Six studies reported the percentage of smokers among both sexes (Figure 41). In 
all studies more men smoked than women (Galobardes et al, 2003; Lee et al, 
2000; Ordunez et al, 2005; Rosvall et al, 2000; Thursten et al, 2005; Sodjinou et 
al, 2008). The difference in smoking rate was much smaller in European countries 
and the USA compared to the study in Taiwan and the study in Benin where the 
smoking rate among men was 14 or 22 times higher than among women (Lee et 
al, 2000; Sodjinou et al, 2008).  
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Figure 41: Prevalence of smoking, depending on gender 
 
4.5.6 Gender difference in prevalence of cardiovascular events 
 
The prevalence of stroke was higher in men in two studies (Freedman et al, 2005; 
Venketasubramanian et al, 2005) and the same among men and women in one 
study (Lee et al, 2000) (Figure 42). 
 
 
Figure 42: Prevalence of stroke, depending on gender 
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Study Group, 2000) (Figure 43). 
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Figure 43: Prevalence of myocardial infarct, depending on gender 
 
4.5.7 Gender difference in cardiovascular mortality 
 
In the two studies which reported the gender difference of cardiovascular mortality 
the rate was significantly higher among men (Lee et al, 2000; U.K. Prospective 
Study Group, 2000) (Figure 44). 
 
 
Figure 44: Mortality rate from cardiovascular diseases, depending on gender 
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4.6 Ethnicity and prevalence of cardiovascular risk factors  
 
4.6.1 Ethnicity and prevalence of diabetes 
 
Five studies reported the prevalence of diabetes among people from different 
ethnicity (Figure 45). In two studies blacks less likely had diabetes than whites 
(Bravata et al, 2005; Ordunez et al, 2005) whereas in one study a higher 
prevalence was found among blacks especially among black women. One study 
showed that diabetes was more prevalent among Hispanics than among non-
Hispanic whites (Meigs et al, 2003). In the study which was performed in the multi-
ethnic Singapore Chinese had the lowest prevalence of diabetes followed by 
Malay and Indians had the highest rate (Deurenberg-Yap et al, 2001). 
 
 
Figure 45: Prevalence of diabetes, depending on ethnicity 
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studies (Bravata et al, 2005; Ordunez et al, 2005) and less likely had hypertension 
in one study with the highest rate among black women (Victor et al, 2004). Among 
Hispanics hypertension was more prevalent than among non-Hispanic whites in 
both sexes as shown in one study (Meigs et al, 2003). In the study of Deurenberg-
Yap et al (2001) the highest rate of hypertension was reported for Malay and no 
significant difference was found between Indians and Chinese. Men from every 
ethnicity more likely had hypertension than women except black women. 
 
 
Figure 46: Prevalence of hypertension, depending on ethnicity 
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Two studies reported the prevalence of hyper- or dyslipidemia in a multi-ethnic 
group (Figure 47). The first study which was performed in Singapore reported a 
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(Deurenberg-Yap et al, 2001). The second study showed a higher prevalence of 
hyperlipidemia among Mexican American women than among non-Hispanic white 
women. In the male group the correlation was reverse with a slightly higher rate of 
hyperlipidemia among white men than black men (Meigs et al, 2003).  
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Figure 47: Prevalence of hyper-/dyslipidemia, depending on ethnicity 
 
4.6.4 Ethnicity and prevalence of obesity 
 
Two studies reported the prevalence of obesity in a multi-ethnic group (Figure 48). 
The first study which was performed in Singapore reported a higher prevalence 
among Malays than among Indians and the lowest prevalence among Chinese 
with a higher prevalence among women in Malay and Indians and a higher 
prevalence among men in Chinese (Deurenberg-Yap et al, 2001). The second 
study reported a higher prevalence of obesity among Mexican American women 
than among non-Hispanic white women. Among men this relationship was reverse 
with a slightly higher prevalence of obesity among white men (Meigs et al, 2003).  
 
 
Figure 48: Prevalence of obesity, depending on ethnicity 
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Three studies compared the average BMI in a multi-ethnic sample-group (Figure 
49). In one study blacks had a higher mean BMI than whites (Victor et al, 2004) 
whereas in the second study there was no significant difference between blacks 
and whites (Ordunez et al, 2005). In both studies black women had a higher BMI 
than black men which was not the case among whites where BMI was the same in 
both sexes in one study and slightly higher in women in the other study. 
Deurenberg-Yap et al (2001) reported the lowest BMI among Chinese men and 
women, the approximately same BMI among Malay and Indian men and a higher 
BMI in Malay women than in Indian women.  
 
 
Figure 49: Mean BMI, depending on ethnicity 
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Figure 50: Prevalence of smoking, depending on ethnicity 
 
4.6.6 Ethnicity and prevalence of cardiovascular events 
 
In three studies the prevalence of stroke in a certain time period among people 
from different ethnicity was reported (Figure 51). In two studies whites had a 
higher rate than blacks (Bravata et al, 2005; Freedman et al, 2005), especially 
diabetic men (Freedman et al, 2005). In a study performed in Singapore stroke 
was most prevalent among Chinese and less prevalent among Indians regarding 
both sexes (Venketasubramanian et al, 2005). This trend was mainly caused by 
the male prevalence of stroke whereas among women there was nearly no 
difference between Malay and Indian women. 
 
 
Figure 51: Prevalence of stroke, depending on ethnicity 
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The prevelance of myocardial infarct among people from different ethnicity was 
tested in three studies (Figure 52). In one study the prevalence of MI was higher 
among blacks (Bravata et al, 2005) than among whites and in two studies with 
diabetic patients it was reverse (Freedman et al, 2005; UK Prospective Diabetes 
Study Group, 2000). Interestingly in one study the prevalence of myocardial infarct 
in black women exceeded the prevalence of black men (Freedman et al, 2005) 
wherease it was contrary among white diabetic patients and among all patients of 
the second study with a higher prevalence among men. South Asian diabetic 
patients more likely were affected by a myocardial infarct than blacks and less 
likely were affected than whites (UK Prospective Diabetes Study Group, 2000). 
 
 
Figure 52: Prevalence of myocardial infarct, depending on ethnicity 
 
4.6.7 Ethnicity and prevalence of cardiovascular mortality 
 
In the only study which reported the mortality rate from stroke, American Indian 
men and women were affected by a higher rate than whites (Figure 53) (Harwell et 
al, 2008). 
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Figure 53: Mortality rate from stroke, depending on ethnicity 
 
In two studies the influence of ethnicity on mortality rate from myocardial infarct 
was analysed (Figure 54). One study showed that American Indian men and 
women had a higher mortality rate from myocardial infarct (Harwell et al, 2005). In 
the second study white diabetic patients had the highest mortality rate from MI, 
followed by South Asian diabetics and the black Carribean diabetics (UK 
Prospective Diabetes Study Group, 2000). 
 
 
Figure 54: Mortality rate from myocardial infarct, depending on ethnicity 
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4.7 Socioeconomic status and prevalence of cardiovascular risk factors  
 
4.7.1 Socioeconomic status and prevalence of diabetes 
 
In two studies the prevalence of diabetes significantly increased with low 
occupational status in women (Figure 55) (Galobardes et al, 2003; Rosvall et al, 
2000). There was no trend depending on occupational status in the study of 
Galobardes et al (2003). In the study of Rosvall et al (2000) low occupational level 
was associated with a high diabetes rate with exception of the group from the 
highest occupational level which had a very high diabetes rate. In the study of 
Singh-Manoux et al (2008) a socioeconomic gradient of the diabetes rate was 
found. In the Chinese study of Xu et al (2008) high family income was associated 
with a high diabetes rate. 
 
 
Figure 55: Prevalence of diabetes, depending on occupational status, SES or family income 
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Among women the duration of education is negatively associated with the 
prevalence of diabetes as shown in two studies (Figure 56) (Kuper et al, 2007; 
Rosvall et al, 2000). Rosvall et al (2000) showed that men with the lowest 
educational level had the highest diabetes rate, and men with medium educational 
level had the lowest diabetes rate. 
 
 
Figure 56: Prevalence of diabetes, depending on educational status  
 
Urban residents more likely had diabetes than rural residents as it was shown in 
two studies (Figure 57) (Abdul-Rahim et al, 2001; Bouguerra et al, 2006), except 
male urban residents in the study of Abdul-Rahim et al (2001) who had a lower 
diabetes rate than male rural residents.  
 
 
Figure 57: Prevalence of diabetes, depending on residency 
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women the diabetes rate did not differ significantly. The lowest rate was found 
among married women. This profile was different among men where the 
prevalence was lowest in the single group and highest in the divorced group. 
There was no significant difference among married and widowed men. 
 
 
Figure 58: Prevalence of diabetes, depending on marital status 
 
4.7.2 Socioeconomic status and prevalence of hypertension 
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Figure 59: Prevalence of hypertension, depending on SES 
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Three studies evaluated the association of occupational status and hypertension 
(Figure 60). In two of them a lower occupational status was associated with a 
higher occurrence of hypertension (Galobardes et al, 2003; Rosvall et al, 2000). In 
the study of Santos et al (2008) active persons had a significantly lower 
prevalence of hypertension than unempoyed and retired persons or housewives. 
 
 
Figure 60: Prevalence of hypertension, depending on occupational status 
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hypertension. In all three studies a significant association between a low duration 
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medium or low education level. 
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Figure 61: Prevalence of hypertension, depending on educational status 
 
The prevalence of hypertension was slightely higher among male and female 
urban residents than among rural residents in the study of Bouguerra et al (2006) 
(Figure 62). This relationship was inverse in the study of Abdul-Rahim et al (2001), 
especially among men.  
 
 
Figure 62: Prevalence of hypertension, depending on residency 
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In two studies the association of the prevalence of hypertension with marital status 
was analysed (Figure 63). In the study of Santos et al (2008) hypertension was 
more prevalent in the married group than in the not married group. Ikeda et al 
(2007) found the highest occurrence of hypertension among widowed women 
followed by married and divorced women. This profile differed among men where 
the highest rate was found among the divorced group, followed by the married and 
widowed group. Single men and women had the lowest hypertension rate. 
 
 
Figure 63: Prevalence of hypertension, depending on marital status 
 
4.7.3 Socioeconomic status and prevalence of hyper-/dyslipidemia 
 
Three studies analysed the influence of occupational status on the prevalence of 
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exception of the medium class which has the lowest prevalence. In the study of 
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class (Social class V) whereas “Social class II” had the highest prevalence of 
hyperlipidemia. Furthermore in this study hyperlipidemia was most prevalent 
among housewives and less prevalent among the retired group. In the study of 
Singh-Manoux et al (2008) there was no significant difference in occurrence of 
hyper-or dyslipidemia between people from different SES. 
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Figure 64: Prevalence of hyper-/dyslipidemia, depending on occupational status  
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education had the highest rate and men with medium education had the lowest 
rate. 
 
 
Figure 65: Prevalence of hyper-/dyslipidemia, depending on educational status 
 
The prevalence of hyper- or dyslipidemia was higher among urban residents than 
among rural residents as reported in two studies (Abdul-Rahim et al, 2001; 
Bouguerra et al, 2006). This trend was shown in men and women (Figure 66). 
 
 
Figure 66: Prevalence of hyper-/dyslipidemia, depending on residency 
 
In the study of Santos et al (2008) hyper- or dyslipidemia was more prevalent 
among the married than among the not married group (Figure 67). 
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Figure 67: Prevalence of hyper-/dyslipidemia, depending on marital status 
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Figure 68: Prevalence of obesity, depending on occupational status 
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In two studies the prevalence of obesity was higher among urban than rural 
residents in both sexes (Abduhl-Rahim et al, 2001; Bouguerra et al, 2006) (Figure 
69). Furthermore in these two studies performed in West-Bank and Tunisia, 
women were more likely obese than men. 
 
 
Figure 69: Prevalence of obesity, depending on urban or rural residency 
 
In the study of Santos et al (2008) married people were more likely obese than not 
married people (Figure 70). 
 
 
Figure 70: Prevalence of obesity, depending on marital status 
 
In the only study which analysed the association of obesity rate with educational 
status, people with the shortest education duration were more likely obese then 
those with a higher education duration (Santos et al, 2008) (Figure 71). 
 
 
Figure 71: Prevalence of obesity, depending on educational duration 
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The association of mean BMI and occupational status was analysed in three 
studies. In all three studies there was a significant association between low 
occupational status and higher BMI among women (Figure 72)(Galobardes et al, 
2003; MacFadden et al, 2008; Rosvall et al, 2000). This trend was not as 
significant among men. 
 
 
Figure 72: Mean BMI, depending on occupational status 
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among single men and women and slightely lower in the divorced group as in the 
widowed and married group of both sexes. 
 
 
Figure 73: Mean BMI, depending on marital status 
 
In three studies the association of mean BMI and educational level was analysed. 
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exception were men in the study of MacFadden et al (2008) among who BMI did 
not differ with educational level. 
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Figure 74: Mean BMI, depending on educational status 
 
4.7.5 Socioeconomic status and prevalence of smoking 
 
Six studies analysed the smoking rate depending on SES (Figure 75). In all the 
studies smoking rate was higher among the groups from lower SES. Three studies 
showed a correlation of low occupational status with a higher prevalence of 
smoking. This association was higher among men than among women 
(Galobardes et a, 2003; MacFadden et al, 2008; Rosvall et al, 2000). The study of 
Singh-Manoux (2008) showed a significant association of low SES with a high 
smoking rate and the study of Xu et al (2008) showed an association of a high 
family income with a high smoking rate. In the study of Dragano et al (2007) the 
neighbourhood unemployment with Quartile IV defined as the highest 
unemployment and Quartile I defined as the lowest unemployment was positively 
correlated with the smoking rate in Germany and in the Czech Republic. The 
second parameter, neighbourhood overcrowding also was positively correlated 
with the smoking rate in both countries.  
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Figure 75: Smoking rate, depending on SES or occupational class 
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In the study of Ikeda et al (2007) the association of smoking rate and marital status 
was analysed (Figure 76). Men had a much higher smoking rate than women. 
Among both sexes the rate was highest in divorced people and lowest in married 
people. Widowed men more likely were smokers than single men whereas this 
was reverse for women. 
 
 
Figure 76: Smoking rate, depending on marital status 
 
In three studies an association of low educational status with high smoking rate in 
men and women was shown (Figure 77) (Kuper et al, 2007; MacFadden et al, 
2008; Rosvall et al, 2008). 
 
 
Figure 77: Smoking rate, depending on educational status 
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4.7.6 Socioeconomic status and prevalence of cardiovascular events 
 
Three studies analysed the association of SES with various parameters indicating 
for socioeconomic status (Figure 78). In all studies low SES correlated with a 
higher prevalence of stroke. In three of these studies family income (Xu et al, 
2008), occupation (Xu et al, 2008) or general SES were analysed (Engström et al, 
2001); and in two studies educational status was analysed (Kuper et al, 2007; Xu 
et al, 2008). In one study urban residency correlated with a higher prevalence of 
stroke compared to rural residency (Xu et al, 2008). 
 
 
Figure 78: Prevalence of stroke, depending on SES, duration of education and residency 
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In the study of MacFadden et al (2008) low professional and low educational 
status was associated with a higher prevalence of CVD (Figure 79). This trend 
was more significant among men. 
 
 
Figure 79: Prevalence of cardiovascular diseases, depending on profession and education 
 
In the study of Singh-Manoux et al (2008) the prevalence of coronary heart 
diseases was associated with low SES (Figure 80). 
 
 
Figure 80: Prevalence of coronary heart diseases, depending on SES 
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stroke was highest among widowed men. Interestingly in both sexes, the single 
group was affected by the lowest mortality rate. Married women had a lower 
mortality rate than divorced and widowed women whereas married men had a 
higher rate than divorced men. In all groups a higher mortality rate was reported 
among men. 
 
 
Figure 81: Mortality rate from stroke, depending on marital status 
 
In the study of Ikeda et al (2007) mortality rate from CVD was highest among 
widowed men and women and lowest among married men (Figure 82). There was 
no significant difference between the divorced and single group among men 
whereas single women had a higher mortality rate from coronary heart disease 
than divorced women. Married women were affected by a slightly lower mortality 
rate than the single and divirced women. In all four groups men had a higher 
mortality rate than women. 
 
 
Figure 82: Mortality rate from cardiovascular diseases, depending on marital status 
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In the study of Ikeda et al (2007) widowed women had the highest mortality rate 
from coronary heart disease, whereas the mortality rate was similar among single 
and divorced women and lowest among married women (Figure 83). Interestingly, 
the mortality rate of men was highest among the single men followed by the 
married men and lowest among the widowed men. In the group of the married, 
divorced and single people, women were affected by a higher mortality rate than 
men, whereas widowedness caused the highest mortality rate in women which 
exceeded even the rate of single men.  
 
 
Figure 83: Mortality rate from coronary heart diseases, depending on marital status 
 
0,718
0,390
0,512
0,832
0,277
0,996
0,341
0,357
0,00 0,25 0,50 0,75 1,00 1,25 1,50
Ikeda et al, 2007: Married
Ikeda et al, 2007: Widowed
Ikeda et al, 2007: Divorced
Ikeda et al, 2007: Single
Death from  coronary heart disease [ %]
men women
126 
 
5. Discussion 
 
Cardiovascular diseases are the number one cause of death worldwide. The 
prevalence of several risk factors like abdominal obesity, hypertension, hyper- and 
dyslipidemia and diabetes summarised as metabolic syndrome correlates with the 
incidence of cardiovascular morbidity and mortality. Several lifestyle factors like 
smoking, physical activity and alcohol intake influence the developing of 
cardiovascular risk factors and so the progression of cardiovascular diseases. 
In this meta-analysis including 78 studies an association of gender, ethnicity and 
socioeconomic status on the occurrence, outcome, and mortality rate from 
cardiovascular diseases was found. Furthermore cardiovascular risk factors and 
lifestyle risk factors varied with gender, ethnicity and SES. 
In this study various data on the prevalence of the defined outcome variables were 
compared. The absolute values of the prevalence of the different variables like 
cardiovascular risk factors varied due to different definitions of the components of 
metabolic syndrome. Several studies used criteria from ATPIII (NCEP, 2002) and 
other studies used criteria of WHO (Khatib, 2006), but the comparison of the 
values within one study like between two different subject groups was possible 
which was the goal of the study. Furthermore values also differed because of the 
different age groups which were evaluated in different studies. 
In nearly all studies the number of male CVD patients significantly exceeded the 
number of female patients indicating that more men were affected by a CVD than 
women. Women were significantly older at the first incidence of a CVD. On 
average women were 5.7 years older than men and the age difference ranged 
from one to nine years. Female patients with CVD had a higher prevalence of 
cardiovascular risk factors. The mean prevalence of hypertension and diabetes 
among CVD patients was significantly higher in women and the mean prevalence 
of dyslipidemia was slightly higher in women. Similar proportions of male and 
female CVD patients were overweight or obese. It has to be considered that 
female patients were significantly older than male patients and as the prevalence 
of cardiovascular risk factors increase with age (EGIR et al, 2002) an age-
adjustment would reduce gender difference in risk factor prevalence. More men 
were current or former smokers. Especially in Asiatic countries the gender 
difference in smoking rate was very high. The prevalence of recurrent 
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cardiovascular events within 28 days was higher in men whereas the prevalence 
within one year was higher in women. The mortality rate in hospital or within 28 
days was significantly higher among women whereas the 1 year – mortality rate 
was only slightly higher in women. One has to consider that female CVD patients 
were significantly older than men. Furthermore treatment containing medical 
treatment like thrombolytic therapy or invasive procedures like revascularization, 
cardiac catherisation or percutaneous coronary interventions differed between 
genders with a lower probability for women to get these treatments (Alfredsson et 
al, 2007; Radovanovic et al, 2007; Matsui et al, 2002). After adjustment for age, for 
comorbidities, for social deprivation or for interventions the gender difference in in-
hospital or 28/30-days mortality rate decreased or disappeared. Long-term 
mortality rates (after one year or 2-7 years) were higher in women in all analysed 
studies, whereas after adjustment to age or comorbidites rates were similar or 
even higher in men. 
In one study not only a subject group with patients admitted to hospital with CVD 
were analysed, but also the mortality rate before hospitalization was recorded. The 
probability to survive to reach the hospital was higher in women. So the 30-days 
mortality was significantly higher in women among the admitted patients and only 
slightly higher in women in the patient group including also the patients who did 
not reach hospital alive. It has to be considered that the values of several other 
studies could also change when considering death rates before hospital 
admission. The mean age of patients who did not survive to reach a hospital was 
about 6 to 7 years higher than in the subject group that was admitted to hospital in 
both sexes. The gender difference of age in both groups was 6 years (MacIntyre et 
al, 2002). 
In cross sectional analysis with a healthy or diabetic population men had a higher 
incidence and prevalence of stroke and myocardial infarct and also a higher 
cardiovascular mortality over a defined follow-up period, a finding which was 
consistent to previous literature reports (Roeters van Lennep et al, 2002). 
Because of the necessity of the interaction of more risk factors in women than in 
men to cause a cardiovascular event it was assumed that there are protective 
mechanisms among the female population especially prior to menopause. This 
effect could be explained by female hormones such as estrogen which protects 
women from cardiovascular disease. Several studies have tried to find an 
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explanation on the protective effect of the female sexual hormones. Estrogen 
improves cardiovascular risk factors like lipid profile by increasing the HDL-level 
and decreasing the LDL-level. Furthermore estrogen directly improves vascular 
function by increasing nitric oxide synthase activity and so NO production which 
has beneficial effects on endothelial dysfunction. It was also shown that estrogen 
decreases LDL oxidation and so contributes to the prevention of foam cell 
formation and lesion progression (Medina et al, 2003; Roeters van Lennep et al, 
2002) and improves heart function and health. 17ß-estradiol was demonstrated to 
inhibit cardiomyocyte apoptosis in vitro and in vivo in mice (Patten et al, 2004). 
This fact could explain that in men’s hearts myocyte cells are lost during aging, an 
observation which is not made in women’s heart (Olivetti et al, 1995). In studies 
with mice it was shown that estrogen and testosterone had opposing effects on 
chronic cardiac remodeling and function after MI. Estrogen seems to prevent 
destroying of cardiac function, but testosterone seems to increase cardiac 
dysfunction (Cavasin et al, 2003). In cell culture experimental stroke caused less 
injury in female than male culture, an effect maybe attributable to female sex 
hormones (Li et al, 2005). 
After menopause women are more often affected by cardiovascular events due to 
hormonal changes like a decline of protecting estrogens in blood. There are 
converse opinions on influence of exogenous hormonal treatment such as 
hormone replacement therapy. Collins et al (2002) could not find a benefit of 
hormone replacement therapies. Kuh et al (2005) showed that postmenopausal 
women had higher levels of metabolic risk factors compared with premenopausal 
or perimenopausal women of the same age. During hormone replacement therapy 
levels of metabolic risk factors decreased and might protect against cardiovascular 
disease. Additionally the typical male pattern of fat distribution which means 
increased visceral adiposity correlated with a greater risk of myocardial infarct 
(Yusuf et al, 2005).  
Besides these biological factors, psychosocial factors seem to influence gender 
difference in CVD morbidity and mortality. In a recent study a higher “femininity” 
scores in men and so a lower stereotypically masculine self-image was associated 
with a lower risk of cardiovascular mortality. It is suggested that social constructs 
are important for health and may explain gender difference in longevity due to the 
substantial contribution of CHD to premature mortality (Hunt et al, 2007).  
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Furthermore the prevalence of cardiovascular risk factors in studies with a healthy 
population was higher in men in most European or North American studies but not 
in second world or developing countries like West-Bank, Benin, Taiwan. The 
prevalence of obesity was higher in men in most European studies whereas the 
prevalence was higher in women in studies performed in Benin, Europe, USA, 
Singapore, Cuba, Tunisia and West-Bank.  
The higher occurrence of risk factors of women in developing countries and in 
emerging markets could be explained by the higher susceptibility of women for 
rapid transition from undernutrition to overnutrition (Delisle et al, 2008). 
In nearly all countries men more often were smokers than women. The higher 
prevalence of risk factors in men in several European or North American studies 
could be caused by a more adverse lifestyle factor profile like the higher smoking 
rate and an unhealthier diet (Petersen et al, 2005).  
 
Furthermore in this analysis ethnicity had a significant influence on CVD risk 
factors and CVD prevalence. Native Americans and blacks were affected by a 
cardiovascular event at the youngest age, followed by Hispanics. Asians and 
whites were significantly older than blacks and Hispanics. Hispanic CVD patients 
more likely had diabetes and hypertension than blacks, whites or Asians. Blacks 
more likely had diabetes and hypertension than Asians and whites and Asians had 
the lowest BMI. The prevalence of hyper- or dyslipidemia was higher in whites 
than in blacks and higher in blacks than in Asians. The cardiovascular risk factor 
profile was worse among Native Americans. In-hospital mortality rate and one-year 
mortality was slightly higher in Asians than in whites and not significantly different 
between Hispanics and non-Hispanic whites. Blacks had the lowest in-hospital 
mortality rate and a slightly lower one-year mortality rate than whites. It has to be 
considered that blacks are significantly younger than whites and Asians, so that an 
age-adjustment of in-hospital and one-year mortality could reduce or invert this 
lower rate of blacks. In one study black women had the highest mortality rate. It 
was suggested that the high prevalence of diabetes caused this low survival rate 
after one year (Quresi et al, 2006). The two-year mortality rate was lowest in 
Asians and highest in blacks. The significantly higher long-term mortality rate of 
blacks might be caused by ethnic difference in the pathophysiology of 
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cardiovascular diseases like the higher calcification of plaques during 
atherosclerosis (Detrano et al, 2003).  
In cross sectional analysis of a healthy population the prevalence of 
cardiovascular risk factors was higher in Hispanics than whites and highest among 
black women. The prevalence of myocardial infarct and stroke and the mortality 
rate from myocardial infarct was slightly higher in white men than in women and in 
people from other ethnicity.  
Literature reports showed significantly increased cardiovascular risks for blacks 
and slightly increased risks for Hispanics compared to whites which was 
independent of education and income (Seeman et al, 2008). Another study 
showed that an elevated risk for diabetes at same BMI for blacks, Asians and 
Hispanics compared to whites was found. This association of increasing BMI and 
greater weight gain and risk of diabetes was most pronounced among Asians 
(Shai et al, 2006).  
The ethnic differences are partly related to socioeconomic differences because of 
the lower socioeconomic status or education of certain ethnic groups like blacks 
(Seeman et al, 2008).  
One has to consider that in this analysis mostly the CVD prevalence of people with 
non-white ethnicity in countries with a white majority was compared. The 
prevalence of cardiovascular events or the occurrence of risk factor can differ 
significantly in their or their ancestor’s original countries. Immigration was 
positively associated with increased burden of cardiovascular risk profile and sub-
clinical atherosclerosis and increased over time as shown among Africans and 
Asians (Lear et al, 2009; Dominguez et al, 2008; Woo et al, 1999). Brondolo et al 
(2008) reported that perceived racism of blacks and Latinos was positively 
associated with nocturnal ambulatory blood pressure and so with an increased 
CVD risk even after adjusting to SES. 
In a multic-ethnic study in Singapore Malay had the highest prevalence of obesity 
and hypertension whereas Indian people had the highest rate of dyslipidemia and 
diabetes. Interestingly, in another study included in this meta-analysis Chinese 
had a slightly higher stroke risk than Malay and Indians. The distribution of 
cardiovascular risk factors between the three ethnic groups was similar in another 
study performed in Singapore. In this study the highest prevalence of hypertension 
was found in Malay and the adverse lipid profile and the highest diabetes rate was 
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found in Indians. More Indians were overweight than Chinese or Malay and only 
slightly more Malay were obese than Indians (Ma et al, 2003). In addition to a 
higher prevalence of diabetes, Malays with diabetes had mortality rates which 
were nearly twice of those of Chinese and the rate of Indians with diabetes was 
more than threefold compared to a Chinese with diabetes (Ma et al, 2003). 
Another study showed that ethnicity was a significant predictor of cardiovascular 
disease even after adjustment for cardiovascular risk factors with the highest CVD 
risk for Indians (Lee et al, 2001). The multi-ethnic state Singapore has undergone 
rapid economic development over the past 30 years and urbanization which 
affected all three ethnic groups simultaneously. Distribution of socioeconomic 
class was relatively homogenous between people with different ethnicity. 
However, the three ethnic groups have not been equally affected by these 
changes when regarding cardiovascular risk factor prevalence, morbidity and 
mortality (Ma et al, 2003). 
 
Furthermore the socioeconomic status influenced the prevalence of cardiovascular 
risk factors and diseases. The definition of the socioeconomic factors was very 
heterogeneous and they were mainly divided into general socioeconomic status, 
occupational class, educational class, residency and marital status. The age of 
CVD patients was only influenced by educational status with the youngest age in 
the group with medium educational level. The prevalence of diabetes and obesity 
among CVD patients was higher in groups with low SES. The same correlation 
was found with hypertension which was positively associated with low SES with 
the exception of one study where the relation was reverse. The in-hospital and 28-
days-mortality was higher in the lowest income group. 
In cross-sectional analysis with healthy patients a higher prevalence of the 
cardiovascular risk factors diabetes, hypertension, hyper- or dyslipidemia, obesity 
and smoking and a higher mean BMI was associated with a low SES indicated by 
educational or occupational status. In two studies performed in Africa or the Middle 
East an adverse risk factor profile correlated with urban residency. Furthermore 
occurrence of cardiovascular events was significantly correlated with low SES with 
a higher occurrence among men in all socioeconomic groups. These results go 
conform to literature report which showed a significant education and income 
gradient in cardiovascular, metabolic and inflammatory risk. This socioeconomic 
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and educational gradient in cardiovascular morbidity and mortality was seen within 
various ethnic groups (Seeman et al, 2008). In the study of Kivimäki et al (2007) it 
was shown that behavioural related risk factors like smoking, heavy alcohol 
consumption and physical inactivity were associated with low SES. Nevertheless 
these risk factors did not fully explain the socioeconomic difference of CHD. 
Another study reported that emotional stress was significantly associated with 
coronary heart disease risk in a low socioeconomic community (Kim et al, 2008). 
In contrast to another study which could not explain the socioeconomic gradient in 
the prevalence of the metabolic syndrome with psychosocial risk factors like 
fatigue and depression, perceived stress, social network and cohabitation and 
behavioural risk factors like smoking, alcohol and physical activity and low SES 
(Prescott et al, 2007). 
Furthermore marital status influenced the occurrence of cardiovascular risk factors 
and the mortality rate. An especially adverse risk factor profile and mortality rate 
was found in divorced men. Most data was obtained from only one Japanese 
study and could vary in other countries.  
 
Conclusion 
 
Women were older than men at the incidence of the first cardiovascular event and 
had more likely hypertension and diabetes, but not significantly more likely 
hyperlipidemia and obesity. Women with CVD had a higher mortality rate which 
was not the case for age-adjusted mortality rate. The prevalence and mortality rate 
of cardiovascular diseases was higher among people of low socioeconomic status. 
Blacks and Hispanics had a higher incidence of cardiovascular risk factors 
compared to whites and Asians especially black women. Indian ethnicity was 
associated with adverse cardiovascular risk compared to Chinese and Malay. The 
prevalence of cardiovascular risk factors in a cross sectional analysis was higher 
among men in studies in Europe or North America, whereas the prevalence was 
higher in women in second world or developing countries. For developing global 
strategies to reduce cardiovascular burden the gender, ethnic and socioeconomic 
influences on cardiovascular risk factors, morbidity and mortality should be 
considered. 
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6. Abstract 
 
Cardiovascular diseases (CVDs) are the principal cause of death worldwide. The 
prevalence of several risk factors like abdominal obesity, hypertension, hyper- and 
dyslipidemia and diabetes and lifestyle factors like smoking, physical activity and 
alcohol intake correlates with the incidence of cardiovascular morbidity and 
mortality. In this study a systematic review and meta-analysis was performed to 
evaluate the influence of gender, ethnicity and socioeconomic status (SES) on the 
prevalence and outcome of cardiovascular diseases. Female gender was 
significantly correlated with a higher age at a cardiovascular event and with a 
higher prevalence of diabetes, hypertension and a higher mortality rate among 
CVD patients. In a healthy population the prevalence of cardiovascular risk factors 
was higher in men in most European or North American studies but not in second 
world or developing countries. In nearly all studies men more often were smokers 
than women. Furthermore ethnicity had a significant influence on CVD risk factors 
and CVD prevalence. Native Americans, blacks and Hispanics were affected by a 
cardiovascular event at a younger age than Asians and whites. Native American, 
Hispanic and black CVD patients more likely had diabetes and hypertension than 
whites or Asians. In-hospital mortality rate and one-year mortality was highest 
among Asians and lowest in blacks whereas two-years mortality rate was highest 
in blacks and lowest in Asians. In cross sectional analysis of a healthy population 
the prevalence of cardiovascular risk factors was higher in Hispanics than whites 
and highest among black women. The prevalence of myocardial infarct and stroke 
and the mortality rate from myocardial infarct was highest in white men. Indians 
had the adverse cardiovascular risk compared to Malay and Chinese. Low SES 
indicated by income, occupational class and educational class was associated 
with a higher prevalence of diabetes, hypertension and obesity among CVD 
patients and a higher mortality rate. Among a healthy population a higher 
prevalence of several cardiovascular risk factors correlated with a low SES, 
divorce or urban residency. The occurrence of cardiovascular events was 
significantly correlated with low SES with a higher occurrence among men in all 
socioeconomic groups.  
This analysis implicates that strategies for reducing cardiovascular burden should 
consider gender, ethnic and socioeconomic differences. 
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Zusammenfassung 
 
Kardiovaskuläre Krankheiten stellen weltweit die häufigste Todesursache dar. 
Sämtliche Risikofaktoren wie abdominale Adipositas, Hypertonie, Hyperlipidämie, 
Diabetes und Lebensstilfaktoren wie Rauchen, Bewegung und Alkoholkonsum 
korrelieren mit dem Auftreten kardiovaskulärer Krankheiten. In dieser Meta-
Analyse wurde der Einfluss von Geschlecht, Ethnizität und sozio-ökonomischem 
Status auf die Häufigkeit kardiovaskulärer Krankheiten getestet. Frauen waren 
signifikant älter beim Auftreten kardiovaskulärer Krankheiten und litten an einer 
höheren Diabetes-, Hypertonie- und Mortalitätsrate. In Querschnittstudien von 
einer gesunden Probandengruppe war die Häufigkeit kardiovaskulärer 
Risikofaktoren höher bei Männern in den meisten Europäischen und 
Nordamerikanischen Studien und höher bei Frauen in Schwellen- oder 
Entwicklungsländern. In fast allen Studien waren mehr Männer Raucher als 
Frauen. Außerdem beeinflusste die Ethnizität das Auftreten von kardiovaskulären 
Risikofaktoren und Krankheiten. Amerikanische Ureinwohner, Schwarze und 
Lateinamerikaner waren jünger beim ersten kardiovaskulären Ereignis und hatten 
häufiger Diabetes und Hypertonie als Asiaten und Weiße. Die Mortalitätsrate im 
Krankenhaus und nach einem Jahr war höher bei Asiaten und geringer bei 
Schwarzen während die Mortalitätsrate nach zwei Jahren bei Schwarzen am 
höchsten und bei Asiaten am niedrigsten war. In Querschnittstudien war die 
Häufigkeit von kardiovaskulären Risikofaktoren bei Lateinamerikanern höher als 
bei Weißen und am höchsten bei schwarzen Frauen. Weiße Männer waren am 
stärksten von Herzinfarkt und Schlaganfall betroffen. Inder hatten ein 
ungünstigeres kardiovaskuläres Risiko als Chinesen und Malayen. Niedriger 
sozialer Status gemessen an Ausbildung, Beruf und Einkommen waren mit einer 
höheren Diabetes, Hypertonie und Adipositasrate sowie einer höheren 
Mortalitätsrate assoziiert. In Querschnittstudien korrelierte ein erhöhtes Auftreten 
sämtlicher kardiovaskulärer Risikofaktoren mit niedrigem sozio-ökonomen Status, 
Scheidung und urbanem Wohnsitz. Die Häufigkeit kardiovaskulärer Ereignisse 
korrelierte signifikant mit niedrigem sozio-ökonomischem Status mit einem 
höheren Auftreten unter Männern in allen sozialen Gruppen.  
Strategien zur Reduzierung der globalen kardiovaskulären Epidemie sollten 
Geschlechts-. Ethnizitäts- und soziale Unterschiede berücksichtigen. 
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7. Abbreviations 
 
ABI Ankle-brachial blood pressure index  
ACS acute coronary syndrome 
ATP Adult Treatment Pannel 
BMI body mass index 
CHD coronary heart disease 
CVD cardiovascular disease 
CRP C-reactive protein 
DBP diastolic blood pressure 
ECG electrocardiogram 
EGIR European group for the study of insulin resistance  
HDL high density lipoprotein 
IMT intima media thickness  
LDL low density lipoprotein 
NCEP National Cholesterol Education Program 
PAD peripheral arterial disease 
PCI percutaneous coronary intervention 
SA stable angina 
SBP systolic blood pressure  
SES socioeconomic status 
WHO World Health Organization 
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